(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
☒ | Smaller reporting company | |||
Accelerated filer | ☐ | Emerging growth company | ||
Non-accelerated filer | ☐ |
PART I | Page | |
BUSINESS ............................................................................................................................................................................... | ||
RISK FACTORS ...................................................................................................................................................................... | ||
UNRESOLVED STAFF COMMENTS .................................................................................................................................. | ||
CYBERSECURITY ................................................................................................................................................................. | ||
PROPERTIES ......................................................................................................................................................................... | ||
LEGAL PROCEEDINGS ....................................................................................................................................................... | ||
MINE SAFETY DISCLOSURES .......................................................................................................................................... | ||
PART II | ||
ISSUER PURCHASES OF EQUITY SECURITIES .......................................................................................................... | ||
[RESERVED] ........................................................................................................................................................................... | ||
OPERATIONS ........................................................................................................................................................................ | ||
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK ......................................................... | ||
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA ......................................................................................... | ||
DISCLOSURE ......................................................................................................................................................................... | ||
CONTROLS AND PROCEDURES ...................................................................................................................................... | ||
OTHER INFORMATION ........................................................................................................................................................ | ||
DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS ................................. | ||
PART III | ||
DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE ........................................................... | ||
EXECUTIVE COMPENSATION ........................................................................................................................................... | ||
STOCKHOLDER MATTERS ............................................................................................................................................... | ||
PRINCIPAL ACCOUNTANT FEES AND SERVICES ....................................................................................................... | ||
PART IV | ||
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES ............................................................................................... |
ASU | Accounting Standards Update |
ATM | At the Market |
CIP | Construction in Progress |
EPS | Earnings per Share |
FASB | Financial Accounting Standards Board |
FDA | U.S. Food and Drug Administration |
FDIC | Federal Deposit Insurance Corporation |
FFO | Funds From Operations |
GAAP | U.S. Generally Accepted Accounting Principles |
HVAC | Heating, Ventilation, and Air Conditioning |
IRS | Internal Revenue Service |
JV | Joint Venture |
LEED® | Leadership in Energy and Environmental Design |
Nareit | National Association of Real Estate Investment Trusts |
NAV | Net Asset Value |
NYSE | New York Stock Exchange |
REIT | Real Estate Investment Trust |
RSF | Rentable Square Feet/Foot |
SEC | Securities and Exchange Commission |
SF | Square Feet/Foot |
SoDo | South of Downtown submarket of Seattle |
SOFR | Secured Overnight Financing Rate |
SoMa | South of Market submarket of San Francisco |
U.S. | United States |
VIE | Variable Interest Entity |
RSF | Number of Properties | Annual Rental Revenue | ||||||||||||||||
Market | Operating | Development | Redevelopment | Total | % of Total | Total | % of Total | Per RSF | ||||||||||
Greater Boston | 9,260,235 | 632,850 | 1,601,010 | 11,494,095 | 26% | 64 | $760,564 | 36% | $86.67 | |||||||||
San Francisco Bay Area | 7,680,005 | 394,781 | 366,939 | 8,441,725 | 19 | 65 | 443,345 | 21 | 66.78 | |||||||||
San Diego | 7,382,450 | 921,510 | — | 8,303,960 | 19 | 79 | 326,925 | 16 | 45.97 | |||||||||
Seattle | 3,186,812 | 227,577 | — | 3,414,389 | 8 | 45 | 136,014 | 5 | 46.19 | |||||||||
Maryland | 3,849,928 | — | — | 3,849,928 | 9 | 50 | 144,032 | 7 | 39.53 | |||||||||
Research Triangle | 3,802,204 | — | — | 3,802,204 | 9 | 38 | 116,808 | 6 | 31.53 | |||||||||
New York City | 921,774 | — | — | 921,774 | 2 | 4 | 73,534 | 4 | 90.26 | |||||||||
Texas | 1,845,159 | — | 73,298 | 1,918,457 | 4 | 15 | 44,022 | 2 | 24.99 | |||||||||
Canada | 888,189 | — | 139,311 | 1,027,500 | 2 | 11 | 19,661 | 1 | 23.08 | |||||||||
Non-cluster/other markets | 349,099 | — | — | 349,099 | 1 | 10 | 15,027 | 1 | 59.35 | |||||||||
Properties held for sale | 600,870 | — | — | 600,870 | 1 | 10 | 13,056 | 1 | N/A | |||||||||
North America | 39,766,725 | 2,176,718 | 2,180,558 | 44,124,001 | 100% | 391 | $2,092,988 | 100% | $56.98 | |||||||||
4,357,276 |
Operating Properties | Operating and Redevelopment Properties | |||||||||||
Market | 12/31/24 | 12/31/23 | 12/31/22 | 12/31/24 | 12/31/23 | 12/31/22 | ||||||
Greater Boston | 94.8% | 94.9% | 94.5% | 80.8% | 84.7% | 85.5% | ||||||
San Francisco Bay Area | 93.3 | 94.8 | 96.7 | 89.1 | 91.4 | 93.3 | ||||||
San Diego | 96.3 | 94.1 | 95.4 | 96.3 | 94.1 | 95.4 | ||||||
Seattle | 92.4 | 95.2 | 97.0 | 92.4 | 90.7 | 90.1 | ||||||
Maryland | 95.7 | 95.6 | 95.8 | 95.7 | 95.6 | 93.3 | ||||||
Research Triangle | 97.4 | 97.8 | 94.0 | 97.4 | 97.8 | 85.0 | ||||||
New York City | 88.4 | (1) | 85.3 | 92.3 | 88.4 | 85.3 | 92.3 | |||||
Texas | 95.5 | 95.1 | 91.2 | 91.8 | 91.5 | 81.6 | ||||||
Subtotal | 94.8 | 94.9 | 95.1 | 90.0 | 90.7 | 89.9 | ||||||
Canada | 95.9 | 87.1 | 80.8 | 82.9 | 73.0 | 68.2 | ||||||
Non-cluster/other markets | 72.5 | 78.5 | 75.0 | 72.5 | 78.5 | 75.0 | ||||||
North America | 94.6% | (2) | 94.6% | 94.8% | 89.7% | 90.2% | 89.4% |
Remaining Lease Term(1) (in Years) | Aggregate RSF | Annual Rental Revenue(1) | Percentage of Annual Rental Revenue(1) | Investment-Grade Credit Ratings | Average Market Cap (in billions) | ||||||||||||||||||
Tenant | Moody’s | S&P | |||||||||||||||||||||
1 | Eli Lilly and Company | 8.4 | 1,122,777 | $ | 90,259 | 4.3% | A1 | A+ | $769.8 | ||||||||||||||
2 | Moderna, Inc. | 11.3 | 634,045 | 90,103 | 4.3 | — | — | $35.1 | |||||||||||||||
3 | Bristol-Myers Squibb Company | 5.4 | 999,379 | 77,188 | 3.7 | A2 | A | $100.6 | |||||||||||||||
4 | Takeda Pharmaceutical Company Limited | 10.4 | 549,759 | 47,899 | 2.3 | Baa1 | BBB+ | $44.2 | |||||||||||||||
5 | Roche | 8.2 | 647,069 | 37,405 | 1.8 | Aa2 | AA | $232.8 | |||||||||||||||
6 | Illumina, Inc. | 5.9 | 857,967 | 35,924 | 1.7 | Baa3 | BBB | $20.6 | |||||||||||||||
7 | Alphabet Inc. | 2.8 | 625,015 | 34,899 | 1.7 | Aa2 | AA+ | $2,032.2 | |||||||||||||||
8 | 2seventy bio, Inc.(2) | 8.7 | 312,805 | 33,543 | 1.6 | — | — | $0.2 | |||||||||||||||
9 | United States Government | 5.6 | 429,359 | 28,861 | 1.4 | Aaa | AA+ | $— | |||||||||||||||
10 | Cloud Software Group, Inc. | 2.2 | (3) | 292,013 | 28,537 | 1.4 | — | — | $— | ||||||||||||||
11 | Novartis AG | 3.5 | 448,690 | 27,958 | 1.3 | Aa3 | AA- | $235.1 | |||||||||||||||
12 | Uber Technologies, Inc. | 57.8 | (4) | 1,009,188 | 27,787 | 1.3 | Baa2 | BBB- | $147.7 | ||||||||||||||
13 | AstraZeneca PLC | 4.8 | 450,848 | 27,226 | 1.3 | A2 | A+ | $226.6 | |||||||||||||||
14 | Boston Children's Hospital | 12.2 | 309,231 | 26,154 | 1.2 | Aa2 | AA | $— | |||||||||||||||
15 | The Regents of the University of California | 6.4 | 372,647 | 23,515 | 1.1 | Aa2 | AA | $— | |||||||||||||||
16 | Sanofi | 6.0 | 267,278 | 21,444 | 1.0 | A1 | AA | $127.9 | |||||||||||||||
17 | Merck & Co., Inc. | 8.5 | 337,703 | 21,401 | 1.0 | A1 | A+ | $300.0 | |||||||||||||||
18 | New York University | 7.1 | 218,983 | 21,056 | 1.0 | Aa2 | AA- | $— | |||||||||||||||
19 | Charles River Laboratories, Inc. | 10.3 | 255,635 | 20,578 | 1.0 | — | — | $11.1 | |||||||||||||||
20 | Massachusetts Institute of Technology | 5.0 | 237,849 | 20,228 | 1.0 | Aaa | AAA | $— | |||||||||||||||
Total/weighted-average | 9.3 | (4) | 10,378,240 | $741,965 | 35.4% |
Stable Cash Flows From Our High-Quality and Diverse Mix of Approximately 800 Tenants | ||||||
Investment-Grade or Publicly Traded Large Cap Tenants | ||||||
92% | ||||||
of ARE’s Top 20 Tenant Annual Rental Revenue | ||||||
52% | ||||||
Percentage of ARE’s Annual Rental Revenue | of ARE’s Annual Rental Revenue | |||||
Solid Historical Occupancy of 96% Over Past 10 Years(2) From Historically Strong Demand for Our Class A/A+ Properties in AAA Locations | ||||||
Annual Rental Revenue | Occupancy Across Key Locations | |||||
Percentage of ARE’s Annual Rental Revenue | ||||||
Long-Duration and Stable Cash Flows From High-Quality and Diverse Tenants | ||
Long-Duration Lease Terms | ||
9.3 Years | ||
Top 20 Tenants | ||
7.5 Years | ||
All Tenants | ||
Weighted-Average Remaining Term(1) |
Sustained Strength in Tenant Collections(2) | ||
99.9% | ||
For the Three Months Ended December 31, 2024 | ||
99.5% | ||
January 2025 |
Occupancy Percentage | |||||||||||||||||||
RSF | Number of Properties | Annual Rental Revenue | |||||||||||||||||
Operating | Operating and Redevelopment | ||||||||||||||||||
Market / Submarket / Address | Operating | Development | Redevelopment | Total | |||||||||||||||
Greater Boston | |||||||||||||||||||
Cambridge/Inner Suburbs | |||||||||||||||||||
Megacampus: Alexandria Center® at Kendall Square | 2,199,030 | — | — | 2,199,030 | 7 | $228,062 | 100.0% | 100.0% | |||||||||||
50(1), 60(1), 75/125(1), 100(1), and 225(1) Binney Street, 140 First Street, and 300 Third Street(1) | |||||||||||||||||||
Megacampus: Alexandria Center® at One Kendall Square | 1,281,580 | — | 104,956 | 1,386,536 | 12 | 145,576 | 94.8 | 87.6 | |||||||||||
One Kendall Square (Buildings 100, 200, 300, 400, 500, 600/700, 1400, 1800, and 2000), 325 and 399 Binney Street, and One Hampshire Street | |||||||||||||||||||
Megacampus: Alexandria Technology Square® | 1,185,190 | — | — | 1,185,190 | 7 | 110,969 | 97.7 | 97.7 | |||||||||||
100, 200, 300, 400, 500, 600, and 700 Technology Square | |||||||||||||||||||
Megacampus: The Arsenal on the Charles | 776,781 | 36,444 | 308,446 | 1,121,671 | 13 | 47,730 | 99.4 | 71.2 | |||||||||||
311, 321, and 343 Arsenal Street, 300, 400, and 500 North Beacon Street, 1, 2, 3, and 4 Kingsbury Avenue, and 100, 200, and 400 Talcott Avenue | |||||||||||||||||||
Megacampus: 480 Arsenal Way, 446, 458, 500, 550 Arsenal Street, and 99 Coolidge Avenue(1) | 633,056 | 204,395 | — | 837,451 | 6 | 28,173 | 98.4 | 98.4 | |||||||||||
Cambridge/Inner Suburbs | 6,075,637 | 240,839 | 413,402 | 6,729,878 | 45 | 560,510 | 98.2 | 91.9 | |||||||||||
Fenway | |||||||||||||||||||
Megacampus: Alexandria Center® for Life Science – Fenway | 1,291,019 | 392,011 | 137,675 | 1,820,705 | 3.0 | 100,587 | 89.7 | 81.1 | |||||||||||
401 and 421(1) Park Drive and 201 Brookline Avenue(1) | |||||||||||||||||||
Seaport Innovation District | |||||||||||||||||||
5 and 15(1) Necco Street | 441,396 | — | — | 441,396 | 2 | 44,143 | 81.8 | 81.8 | |||||||||||
Seaport Innovation District | 441,396 | — | — | 441,396 | 2 | 44,143 | 81.8 | 81.8 | |||||||||||
Route 128 | |||||||||||||||||||
Megacampus: Alexandria Center® for Life Science – Waltham | 466,094 | — | 596,064 | 1,062,158 | 5 | 36,659 | 100.0 | 43.9 | |||||||||||
40, 50, and 60 Sylvan Road, 35 Gatehouse Drive, and 840 Winter Street | |||||||||||||||||||
19, 225, and 235 Presidential Way | 585,226 | — | — | 585,226 | 3 | 13,937 | 100.0 | 100.0 | |||||||||||
Route 128 | 1,051,320 | — | 596,064 | 1,647,384 | 8 | 50,596 | 100.0 | 63.8 | |||||||||||
Other | 400,863 | — | 453,869 | 854,732 | 6 | 4,728 | 59.7 | 28.0 | |||||||||||
Greater Boston | 9,260,235 | 632,850 | 1,601,010 | 11,494,095 | 64 | $760,564 | 94.8% | 80.8% | |||||||||||
Refer to “New Class A/A+ development and redevelopment properties: summary of pipeline” in Item 2 and “Megacampus” under “Definitions and reconciliations” in Item 7 for additional details. (1)We own a partial interest in this property through a real estate joint venture. Refer to “Consolidated and unconsolidated real estate joint ventures” in Item 7 for additional details. | |||||||||||||||||||
Occupancy Percentage | |||||||||||||||||||
RSF | Number of Properties | Annual Rental Revenue | |||||||||||||||||
Operating | Operating and Redevelopment | ||||||||||||||||||
Market / Submarket / Address | Operating | Development | Redevelopment | Total | |||||||||||||||
San Francisco Bay Area | |||||||||||||||||||
Mission Bay | |||||||||||||||||||
Megacampus: Alexandria Center® for Science and Technology – Mission Bay(1) | 2,005,369 | 109,435 | — | 2,114,804 | 10 | $90,452 | 95.1% | 95.1% | |||||||||||
1455(2), 1515(2), 1655, and 1725 Third Street, 409 and 499 Illinois Street, 1450(3), 1500, and 1700 Owens Street, and 455 Mission Bay Boulevard South | |||||||||||||||||||
Mission Bay | 2,005,369 | 109,435 | — | 2,114,804 | 10 | 90,452 | 95.1 | 95.1 | |||||||||||
South San Francisco | |||||||||||||||||||
Megacampus: Alexandria Technology Center® – Gateway(1) | 1,408,022 | — | 259,689 | 1,667,711 | 12 | 76,705 | 81.9 | 69.1 | |||||||||||
600(2), 601, 611, 630(2), 650(2), 651, 681, 685, 701, 751, 901(2), and 951(2) Gateway Boulevard | |||||||||||||||||||
Megacampus: Alexandria Center® for Advanced Technologies – South San Francisco | 812,453 | — | 107,250 | 919,703 | 5 | 52,990 | 100.0 | 88.3 | |||||||||||
213(1), 249, 259, 269, and 279 East Grand Avenue | |||||||||||||||||||
Alexandria Center® for Life Science – South San Francisco | 504,053 | — | — | 504,053 | 3 | 32,767 | 93.9 | 93.9 | |||||||||||
201 Haskins Way and 400 and 450 East Jamie Court | |||||||||||||||||||
Megacampus: Alexandria Center® for Advanced Technologies – Tanforan | 445,232 | — | — | 445,232 | 2 | 3,829 | 100.0 | 100.0 | |||||||||||
1122 and 1150 El Camino Real | |||||||||||||||||||
Alexandria Center® for Life Science – Millbrae(1) | — | 285,346 | — | 285,346 | 1 | — | N/A | N/A | |||||||||||
230 Harriet Tubman Way | |||||||||||||||||||
500 Forbes Boulevard(1) | 155,685 | — | — | 155,685 | 1 | 10,680 | 100.0 | 100.0 | |||||||||||
South San Francisco | 3,325,445 | 285,346 | 366,939 | 3,977,730 | 24 | 176,971 | 91.4 | 82.3 | |||||||||||
Greater Stanford | |||||||||||||||||||
Megacampus: Alexandria Center® for Life Science – San Carlos | 738,038 | — | — | 738,038 | 9 | 41,671 | 94.5 | 94.5 | |||||||||||
825, 835, 960, and 1501-1599 Industrial Road | |||||||||||||||||||
Alexandria Stanford Life Science District | 704,560 | — | — | 704,560 | 9 | 75,771 | 98.5 | 98.5 | |||||||||||
3160, 3165, 3170, and 3181 Porter Drive and 3301, 3303, 3305, 3307, and 3330 Hillview Avenue | |||||||||||||||||||
3412, 3420, 3440, 3450, and 3460 Hillview Avenue | 340,103 | — | — | 340,103 | 5 | 23,603 | 82.9 | 82.9 | |||||||||||
3875 Fabian Way | 228,000 | — | — | 228,000 | 1 | 9,402 | 100.0 | 100.0 | |||||||||||
2475 and 2625/2627/2631 Hanover Street and 1450 Page Mill Road | 198,558 | — | — | 198,558 | 3 | 15,902 | 89.4 | 89.4 | |||||||||||
2100, 2200, and 2400 Geng Road | 78,501 | — | — | 78,501 | 3 | 4,803 | 100.0 | 100.0 | |||||||||||
3350 West Bayshore Road | 61,431 | — | — | 61,431 | 1 | 4,770 | 100.0 | 100.0 | |||||||||||
Greater Stanford | 2,349,191 | — | — | 2,349,191 | 31 | 175,922 | 94.5 | 94.5 | |||||||||||
San Francisco Bay Area | 7,680,005 | 394,781 | 366,939 | 8,441,725 | 65 | $443,345 | 93.3% | 89.1% | |||||||||||
Refer to “New Class A/A+ development and redevelopment properties: summary of pipeline” in Item 2 and “Megacampus” under “Definitions and reconciliations” in Item 7 for additional details. (1)We own a partial interest in this property through a real estate joint venture. Refer to “Consolidated and unconsolidated real estate joint ventures” in Item 7 for additional details. (2)We own 100% of this property. (3)During the three months ended December 31, 2024, we executed a letter of intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project, with the transaction expected to close in 2025. Accordingly, we adjusted the development project RSF and its related book value to reflect 109,435 RSF, with our ownership share expected to be 25% at completion of the project. Refer to “New Class A/A+ development and redevelopment properties: current projects” in Item 2 for additional details. | |||||||||||||||||||
Occupancy Percentage | |||||||||||||||||||
RSF | Number of Properties | Annual Rental Revenue | |||||||||||||||||
Operating | Operating and Redevelopment | ||||||||||||||||||
Market / Submarket / Address | Operating | Development | Redevelopment | Total | |||||||||||||||
San Diego | |||||||||||||||||||
Torrey Pines | |||||||||||||||||||
Megacampus: One Alexandria Square | 840,192 | 241,504 | — | 1,081,696 | 10 | $47,915 | 99.0% | 99.0% | |||||||||||
3115 and 3215(1) Merryfield Row, 3010, 3013, and 3033 Science Park Road, 10935, 10945, 10955, and 10970 Alexandria Way, 10996 Torreyana Road, and 3545 Cray Court | |||||||||||||||||||
ARE Torrey Ridge | 299,138 | — | — | 299,138 | 3 | 13,263 | 79.7 | 79.7 | |||||||||||
10578, 10618, and 10628 Science Center Drive | |||||||||||||||||||
ARE Nautilus | 218,459 | — | — | 218,459 | 4 | 12,184 | 97.7 | 97.7 | |||||||||||
3530 and 3550 John Hopkins Court and 3535 and 3565 General Atomics Court | |||||||||||||||||||
Torrey Pines | 1,357,789 | 241,504 | — | 1,599,293 | 17 | 73,362 | 94.5 | 94.5 | |||||||||||
University Town Center | |||||||||||||||||||
Megacampus: Campus Point by Alexandria(1) | 1,594,463 | 426,927 | — | 2,021,390 | 10 | 86,469 | 98.0 | 98.0 | |||||||||||
9880(2), 10210, 10260, 10290, and 10300 Campus Point Drive and 4135, 4155, 4161, 4224, and 4242 Campus Point Court | |||||||||||||||||||
Megacampus: 5200 Illumina Way(1) | 792,687 | — | — | 792,687 | 6 | 29,978 | 100.0 | 100.0 | |||||||||||
9625 Towne Centre Drive(1) | 163,648 | — | — | 163,648 | 1 | 6,520 | 100.0 | 100.0 | |||||||||||
University Town Center | 2,550,798 | 426,927 | — | 2,977,725 | 17 | 122,967 | 98.8 | 98.8 | |||||||||||
Sorrento Mesa | |||||||||||||||||||
Megacampus: SD Tech by Alexandria(1) | 878,805 | 253,079 | — | 1,131,884 | 12 | 39,988 | 93.6 | 93.6 | |||||||||||
9605, 9645, 9675, 9725, 9735, 9808, 9855, and 9868 Scranton Road, 5505 Morehouse Drive(2), and 10055, 10065, and 10075 Barnes Canyon Road | |||||||||||||||||||
Megacampus: Sequence District by Alexandria | 801,575 | — | — | 801,575 | 7 | 28,766 | 100.0 | 100.0 | |||||||||||
6260, 6290, 6310, 6340, 6350, 6420, and 6450 Sequence Drive | |||||||||||||||||||
Pacific Technology Park(1) | 544,352 | — | — | 544,352 | 5 | 9,352 | 92.8 | 92.8 | |||||||||||
9389, 9393, 9401, 9455, and 9477 Waples Street | |||||||||||||||||||
Summers Ridge Science Park(1) | 316,531 | — | — | 316,531 | 4 | 11,521 | 100.0 | 100.0 | |||||||||||
9965, 9975, 9985, and 9995 Summers Ridge Road | |||||||||||||||||||
Scripps Science Park by Alexandria | 144,113 | — | — | 144,113 | 1 | 11,379 | 100.0 | 100.0 | |||||||||||
10102 Hoyt Park Drive | |||||||||||||||||||
ARE Portola | 101,857 | — | — | 101,857 | 3 | 4,022 | 100.0 | 100.0 | |||||||||||
6175, 6225, and 6275 Nancy Ridge Drive | |||||||||||||||||||
5810/5820 Nancy Ridge Drive | 83,354 | — | — | 83,354 | 1 | 4,581 | 100.0 | 100.0 | |||||||||||
9877 Waples Street | 63,774 | — | — | 63,774 | 1 | 2,680 | 100.0 | 100.0 | |||||||||||
5871 Oberlin Drive | 33,842 | — | — | 33,842 | 1 | 1,909 | 100.0 | 100.0 | |||||||||||
Sorrento Mesa | 2,968,203 | 253,079 | — | 3,221,282 | 35 | $114,198 | 96.8% | 96.8% | |||||||||||
Refer to “New Class A/A+ development and redevelopment properties: summary of pipeline” in Item 2 and “Megacampus” under “Definitions and reconciliations” in Item 7 for additional details. (1)We own a partial interest in this property through a real estate joint venture. Refer to “Consolidated and unconsolidated real estate joint ventures” in Item 7 for additional details. (2)We own 100% of this property. |
Occupancy Percentage | |||||||||||||||||||
RSF | Number of Properties | Annual Rental Revenue | |||||||||||||||||
Operating | Operating and Redevelopment | ||||||||||||||||||
Market / Submarket / Address | Operating | Development | Redevelopment | Total | |||||||||||||||
San Diego (continued) | |||||||||||||||||||
Sorrento Valley | |||||||||||||||||||
3911, 3931, and 3985 Sorrento Valley Boulevard | 151,406 | — | — | 151,406 | 6 | $3,970 | 54.0% | 54.0% | |||||||||||
11045 and 11055 Roselle Street | 43,233 | — | — | 43,233 | 2 | 2,203 | 100.0 | 100.0 | |||||||||||
Sorrento Valley | 194,639 | — | — | 194,639 | 8 | 6,173 | 64.2 | 64.2 | |||||||||||
Other | 311,021 | — | — | 311,021 | 2 | 10,225 | 100.0 | 100.0 | |||||||||||
San Diego | 7,382,450 | 921,510 | — | 8,303,960 | 79 | 326,925 | 96.3 | 96.3 | |||||||||||
Seattle | |||||||||||||||||||
Lake Union | |||||||||||||||||||
Megacampus: Alexandria Center® for Life Science – Eastlake | 1,152,644 | — | — | 1,152,644 | 9 | 77,461 | 95.6 | 95.6 | |||||||||||
1150, 1201(1), 1208(1), 1551, 1600, and 1616 Eastlake Avenue East, 188 and 199(1) East Blaine Street, and 1600 Fairview Avenue East | |||||||||||||||||||
Megacampus: Alexandria Center® for Life Science – South Lake Union | 381,380 | 227,577 | — | 608,957 | 3 | 21,890 | 99.6 | 99.6 | |||||||||||
400(1) and 701 Dexter Avenue North and 428 Westlake Avenue North | |||||||||||||||||||
219 Terry Avenue North | 31,797 | — | — | 31,797 | 1 | 1,339 | 56.9 | 56.9 | |||||||||||
Lake Union | 1,565,821 | 227,577 | — | 1,793,398 | 13 | 100,690 | 95.8 | 95.8 | |||||||||||
Elliott Bay | |||||||||||||||||||
410 West Harrison Street and 410 Elliott Avenue West | 20,101 | — | — | 20,101 | 2 | 710 | 100.0 | 100.0 | |||||||||||
Bothell | |||||||||||||||||||
Megacampus: Alexandria Center® for Advanced Technologies – Canyon Park | 1,061,778 | — | — | 1,061,778 | 22 | 21,482 | 87.7 | 87.7 | |||||||||||
22121 and 22125 17th Avenue Southeast, 22021, 22025, 22026, 22030, 22118, and 22122 20th Avenue Southeast, 22333, 22422, 22515, 22522, 22722, and 22745 29th Drive Southeast, 21540, 22213, and 22309 30th Drive Southeast, and 1629, 1631, 1725, 1916, and 1930 220th Street Southeast | |||||||||||||||||||
Alexandria Center® for Advanced Technologies – Monte Villa Parkway | 463,449 | — | — | 463,449 | 6 | 12,290 | 90.3 | 90.3 | |||||||||||
3301, 3303, 3305, 3307, 3555, and 3755 Monte Villa Parkway | |||||||||||||||||||
Bothell | 1,525,227 | — | — | 1,525,227 | 28 | 33,772 | 88.5 | 88.5 | |||||||||||
Other | 75,663 | — | — | 75,663 | 2 | 842 | 98.5 | 98.5 | |||||||||||
Seattle | 3,186,812 | 227,577 | — | 3,414,389 | 45 | $136,014 | 92.4% | 92.4% | |||||||||||
Refer to “New Class A/A+ development and redevelopment properties: summary of pipeline” in Item 2 and “Megacampus” under “Definitions and reconciliations” in Item 7 for additional details. (1)We own a partial interest in this property through a real estate joint venture. Refer to “Consolidated and unconsolidated real estate joint ventures” in Item 7 for additional details. |
Occupancy Percentage | |||||||||||||||||||
RSF | Number of Properties | Annual Rental Revenue | |||||||||||||||||
Operating | Operating and Redevelopment | ||||||||||||||||||
Market / Submarket / Address | Operating | Development | Redevelopment | Total | |||||||||||||||
Maryland | |||||||||||||||||||
Rockville | |||||||||||||||||||
Megacampus: Alexandria Center® for Life Science – Shady Grove | 1,692,350 | — | — | 1,692,350 | 20 | $79,076 | 97.5% | 97.5% | |||||||||||
9601, 9603, 9605, 9704, 9708, 9712, 9714, 9800, 9804, 9808, 9900, and 9950 Medical Center Drive, 14920 and 15010 Broschart Road, 9920 Belward Campus Drive, and 9810 and 9820 Darnestown Road | |||||||||||||||||||
1330 Piccard Drive | 131,508 | — | — | 131,508 | 1 | 4,323 | 100.0 | 100.0 | |||||||||||
1405 and 1450(1) Research Boulevard | 114,849 | — | — | 114,849 | 2 | 3,029 | 73.3 | 73.3 | |||||||||||
1500 and 1550 East Gude Drive | 91,359 | — | — | 91,359 | 2 | 1,844 | 100.0 | 100.0 | |||||||||||
5 Research Place | 63,852 | — | — | 63,852 | 1 | 3,082 | 100.0 | 100.0 | |||||||||||
5 Research Court | 51,520 | — | — | 51,520 | 1 | 1,976 | 100.0 | 100.0 | |||||||||||
12301 Parklawn Drive | 49,185 | — | — | 49,185 | 1 | 1,598 | 100.0 | 100.0 | |||||||||||
Rockville | 2,194,623 | — | — | 2,194,623 | 28 | 94,928 | 96.7 | 96.7 | |||||||||||
Gaithersburg | |||||||||||||||||||
Alexandria Technology Center® – Gaithersburg I | 619,061 | — | — | 619,061 | 9 | 19,603 | 93.6 | 93.6 | |||||||||||
9, 25, 35, 45, 50, and 55 West Watkins Mill Road and 910, 930, and 940 Clopper Road | |||||||||||||||||||
Alexandria Technology Center® – Gaithersburg II | 486,301 | — | — | 486,301 | 7 | 18,816 | 100.0 | 100.0 | |||||||||||
700, 704, and 708 Quince Orchard Road and 19, 20, 21, and 22 Firstfield Road | |||||||||||||||||||
20400 Century Boulevard | 81,006 | — | — | 81,006 | 1 | 2,107 | 100.0 | 100.0 | |||||||||||
401 Professional Drive | 63,154 | — | — | 63,154 | 1 | 1,949 | 90.1 | 90.1 | |||||||||||
950 Wind River Lane | 50,000 | — | — | 50,000 | 1 | 1,234 | 100.0 | 100.0 | |||||||||||
620 Professional Drive | 27,950 | — | — | 27,950 | 1 | 1,207 | 100.0 | 100.0 | |||||||||||
Gaithersburg | 1,327,472 | — | — | 1,327,472 | 20 | 44,916 | 96.6 | 96.6 | |||||||||||
Beltsville | |||||||||||||||||||
8000/9000/10000 Virginia Manor Road | 191,884 | — | — | 191,884 | 1 | 2,974 | 97.7 | 97.7 | |||||||||||
101 West Dickman Street(1) | 135,949 | — | — | 135,949 | 1 | 1,214 | 69.9 | 69.9 | |||||||||||
Beltsville | 327,833 | — | — | 327,833 | 2 | 4,188 | 86.1 | 86.1 | |||||||||||
Maryland | 3,849,928 | — | — | 3,849,928 | 50 | 144,032 | 95.7 | 95.7 | |||||||||||
Research Triangle | |||||||||||||||||||
Research Triangle | |||||||||||||||||||
Megacampus: Alexandria Center® for Life Science – Durham | 2,214,887 | — | — | 2,214,887 | 16 | $55,242 | 97.6 | 97.6 | |||||||||||
6, 8, 10, 12, 14, 40, 41, 42, and 65 Moore Drive, 21, 25, 27, 29, and 31 Alexandria Way, 2400 Ellis Road, and 14 TW Alexander Drive | |||||||||||||||||||
Megacampus: Alexandria Center® for Advanced Technologies and AgTech – Research Triangle | 687,824 | — | — | 687,824 | 6 | 31,939 | 99.4 | 99.4 | |||||||||||
6, 8, 10, and 12 Davis Drive and 5 and 9 Laboratory Drive | |||||||||||||||||||
Megacampus: Alexandria Center® for Sustainable Technologies | 364,493 | — | — | 364,493 | 7 | $11,979 | 91.8% | 91.8% | |||||||||||
104, 108, 110, 112, and 114 TW Alexander Drive and 5 and 7 Triangle Drive | |||||||||||||||||||
Refer to “New Class A/A+ development and redevelopment properties: summary of pipeline” in Item 2 and “Megacampus” under “Definitions and reconciliations” in Item 7 for additional details. (1)We own a partial interest in this property through a real estate joint venture. Refer to “Consolidated and unconsolidated real estate joint ventures” in Item 7 for additional details. |
Occupancy Percentage | |||||||||||||||||||
RSF | Number of Properties | Annual Rental Revenue | |||||||||||||||||
Operating | Operating and Redevelopment | ||||||||||||||||||
Market / Submarket / Address | Operating | Development | Redevelopment | Total | |||||||||||||||
Research Triangle (continued) | |||||||||||||||||||
Research Triangle (continued) | |||||||||||||||||||
Alexandria Technology Center® – Alston | 155,731 | — | — | 155,731 | 3 | $4,126 | 94.7% | 94.7% | |||||||||||
100, 800, and 801 Capitola Drive | |||||||||||||||||||
Alexandria Innovation Center® – Research Triangle | 136,722 | — | — | 136,722 | 3 | 4,235 | 99.2 | 99.2 | |||||||||||
7010, 7020, and 7030 Kit Creek Road | |||||||||||||||||||
2525 East NC Highway 54 | 82,996 | — | — | 82,996 | 1 | 3,651 | 100.0 | 100.0 | |||||||||||
407 Davis Drive | 81,956 | — | — | 81,956 | 1 | 3,323 | 100.0 | 100.0 | |||||||||||
601 Keystone Park Drive | 77,595 | — | — | 77,595 | 1 | 2,313 | 100.0 | 100.0 | |||||||||||
Research Triangle | 3,802,204 | — | — | 3,802,204 | 38 | 116,808 | 97.4 | 97.4 | |||||||||||
New York City | |||||||||||||||||||
New York City | |||||||||||||||||||
Megacampus: Alexandria Center® for Life Science – New York City | 742,586 | — | — | 742,586 | 3 | 67,864 | 98.7 | 98.7 | |||||||||||
430 and 450 East 29th Street | |||||||||||||||||||
Alexandria Center® for Life Science – Long Island City | 179,188 | — | — | 179,188 | 1 | 5,670 | 45.7 | 45.7 | |||||||||||
30-02 48th Avenue | |||||||||||||||||||
New York City | 921,774 | — | — | 921,774 | 4 | 73,534 | 88.4 | 88.4 | |||||||||||
Texas | |||||||||||||||||||
Austin | |||||||||||||||||||
Megacampus: Intersection Campus | 1,525,359 | — | — | 1,525,359 | 12 | 39,955 | 99.2 | 99.2 | |||||||||||
507 East Howard Lane, 13011 McCallen Pass, 13813 and 13929 Center Lake Drive, and 12535, 12545, 12555, and 12565 Riata Vista Circle | |||||||||||||||||||
1001 Trinity Street and 1020 Red River Street | 198,972 | — | — | 198,972 | 2 | 895 | 100.0 | 100.0 | |||||||||||
Austin | 1,724,331 | — | — | 1,724,331 | 14 | 40,850 | 99.3 | 99.3 | |||||||||||
Greater Houston | |||||||||||||||||||
Alexandria Center® for Advanced Technologies at The Woodlands | 120,828 | — | 73,298 | 194,126 | 1 | 3,172 | 41.5 | 25.8 | |||||||||||
8800 Technology Forest Place | |||||||||||||||||||
Texas | 1,845,159 | — | 73,298 | 1,918,457 | 15 | 44,022 | 95.5 | 91.8 | |||||||||||
Canada | 888,189 | — | 139,311 | 1,027,500 | 11 | 19,661 | 95.9 | 82.9 | |||||||||||
Non-cluster/other markets | 349,099 | — | — | 349,099 | 10 | 15,027 | 72.5 | 72.5 | |||||||||||
North America, excluding properties held for sale | 39,165,855 | 2,176,718 | 2,180,558 | 43,523,131 | 381 | 2,079,932 | 94.6% | 89.7% | |||||||||||
Properties held for sale | 600,870 | — | — | 600,870 | 10 | 13,056 | 39.6% | 39.6% | |||||||||||
Total – North America | 39,766,725 | 2,176,718 | 2,180,558 | 44,124,001 | 391 | $2,092,988 |
Year Ended December 31, | |||||||||
2024 | 2023 | ||||||||
Including Straight-Line Rent | Cash Basis | Including Straight-Line Rent | Cash Basis | ||||||
(Dollars per RSF) | |||||||||
Leasing activity: | |||||||||
Renewed/re-leased space(1) | |||||||||
Rental rate changes | 16.9% | 7.2% | 29.4% | 15.8% | |||||
New rates | $65.48 | $64.18 | $52.35 | $50.82 | |||||
Expiring rates | $56.01 | $59.85 | $40.46 | $43.87 | |||||
RSF | 3,888,139 | 3,046,386 | |||||||
Tenant improvements/leasing commissions | $46.89 | (2) | $26.09 | ||||||
Weighted-average lease term | 8.5 years | 8.7 years | |||||||
Developed/redeveloped/previously vacant space leased(3) | |||||||||
New rates | $59.44 | $57.34 | $65.66 | $59.74 | |||||
RSF | 1,165,815 | 1,259,686 | |||||||
Weighted-average lease term | 10.0 years | 13.8 years | |||||||
Leasing activity summary (totals): | |||||||||
New rates | $64.16 | $62.68 | $56.09 | $53.33 | |||||
RSF | 5,053,954 | 4,306,072 | |||||||
Weighted-average lease term | 8.9 years | 11.3 years | |||||||
Lease expirations(1) | |||||||||
Expiring rates | $53.82 | $57.24 | $43.84 | $45.20 | |||||
RSF | 5,005,638 | 5,027,773 |
Year | RSF | Percentage of Occupied RSF | Annual Rental Revenue (per RSF)(1) | Percentage of Annual Rental Revenue | ||||||||||||||
2025 | (2) | 3,708,195 | 10.0% | $45.91 | 8.2% | |||||||||||||
2026 | 2,826,993 | 7.7% | $50.73 | 6.9% | ||||||||||||||
2027 | 3,302,598 | 8.9% | $53.80 | 8.6% | ||||||||||||||
2028 | 3,944,440 | 10.7% | $49.78 | 9.5% | ||||||||||||||
2029 | 2,385,914 | 6.5% | $51.30 | 5.9% | ||||||||||||||
2030 | 3,144,561 | 8.5% | $43.11 | 6.5% | ||||||||||||||
2031 | 3,433,958 | 9.3% | $54.76 | 9.1% | ||||||||||||||
2032 | 1,005,689 | 2.7% | $58.96 | 2.9% | ||||||||||||||
2033 | 2,585,813 | 7.0% | $47.77 | 5.9% | ||||||||||||||
2034 | 3,304,105 | 8.9% | $66.90 | 10.6% | ||||||||||||||
Thereafter | 7,291,855 | 19.8% | $73.85 | 25.9% |
2025 Contractual Lease Expirations (in RSF) | Annual Rental Revenue (per RSF)(4) | ||||||||||||
Market | Leased | Negotiating/ Anticipating | Targeted for Future Development/ Redevelopment(1) | Remaining Expiring Leases(2) | Total(3) | ||||||||
Greater Boston | 127,804 | 99,201 | 25,312 | 364,741 | 617,058 | $42.40 | |||||||
San Francisco Bay Area | 245,347 | 184,286 | — | 308,637 | 738,270 | 73.49 | |||||||
San Diego | 144,673 | 18,813 | 278,606 | 202,285 | 644,377 | 20.58 | |||||||
Seattle | — | 12,237 | — | 177,932 | 190,169 | 25.16 | |||||||
Maryland | 51,593 | — | — | 141,349 | 192,942 | 26.28 | |||||||
Research Triangle | 11,632 | 16,334 | — | 170,938 | 198,904 | 44.71 | |||||||
New York City | — | 27,912 | — | 40,347 | 68,259 | 110.42 | |||||||
Texas | — | — | 198,972 | — | 198,972 | N/A | |||||||
Canada | 22,991 | — | — | 65,873 | 88,864 | 20.03 | |||||||
Non-cluster/other markets | — | — | — | 2,300 | 2,300 | 40.17 | |||||||
Subtotal | 604,040 | 358,783 | 502,890 | 1,474,402 | 2,940,115 | 41.78 | |||||||
Key 1Q25 lease expirations(5) | 23,522 | 112,831 | — | 631,727 | 768,080 | 61.67 | |||||||
Total | 627,562 | 471,614 | 502,890 | 2,106,129 | 3,708,195 | $45.91 | |||||||
Percentage of expiring leases | 17% | 13% | 14% | 56% | 100% | ||||||||
2026 Contractual Lease Expirations (in RSF) | Annual Rental Revenue (per RSF)(4) | ||||||||||||
Market | Leased | Negotiating/ Anticipating | Targeted for Future Development/ Redevelopment | Remaining Expiring Leases(2) | Total | ||||||||
Greater Boston | 46,858 | 9,874 | — | 391,196 | 447,928 | $54.42 | |||||||
San Francisco Bay Area | 1,619 | 4,753 | — | 511,665 | 518,037 | 66.72 | |||||||
San Diego | — | — | — | 822,140 | 822,140 | 49.60 | |||||||
Seattle | — | 18,205 | — | 102,551 | 120,756 | 43.62 | |||||||
Maryland | — | — | — | 321,676 | 321,676 | 23.61 | |||||||
Research Triangle | — | 19,753 | — | 115,221 | 134,974 | 45.64 | |||||||
New York City | — | 104,157 | — | 71,470 | 175,627 | 93.58 | |||||||
Texas | — | — | — | — | — | — | |||||||
Canada | — | 247,743 | — | — | 247,743 | 22.24 | |||||||
Non-cluster/other markets | — | — | — | 38,112 | 38,112 | 70.34 | |||||||
Total | 48,477 | 404,485 | — | 2,374,031 | 2,826,993 | $50.73 | |||||||
Percentage of expiring leases | 2% | 14% | 0% | 84% | 100% |
Development and Redevelopment | |||||||||||||
Future Opportunities Subject to Market Conditions and Leasing | |||||||||||||
Operating | Under Construction | Priority Anticipated | Future | Subtotal | Total | ||||||||
Square footage | |||||||||||||
Operating | 39,165,855 | — | — | — | — | 39,165,855 | |||||||
New Class A/A+ development and redevelopment properties | — | 4,357,276 | 2,134,948 | 23,696,280 | 30,188,504 | 30,188,504 | |||||||
Future development and redevelopment square feet currently included in rental properties(1) | — | — | (213,524) | (2,843,150) | (3,056,674) | (3,056,674) | |||||||
Total square footage, excluding properties held for sale | 39,165,855 | 4,357,276 | 1,921,424 | 20,853,130 | 27,131,830 | 66,297,685 | |||||||
Properties held for sale | 600,870 | — | — | 2,390,856 | 2,390,856 | 2,991,726 | |||||||
Total square footage | 39,766,725 | 4,357,276 | 1,921,424 | 23,243,986 | 29,522,686 | 69,289,411 | (2) | ||||||
Investments in real estate | |||||||||||||
Gross book value as of December 31, 2024(3) | $28,878,752 | $3,893,557 | $510,372 | $4,452,537 | $8,856,466 | $37,735,218 | |||||||
Property | Submarket/Market | Date of Purchase | Number of Properties | Operating Occupancy | Square Footage | Purchase Price | |||||||||
Future Development(1) | Operating With Future Development/ Redevelopment(1) | ||||||||||||||
Completed during the year ended December 31, 2024: | |||||||||||||||
285, 299, 307, and 345 Dorchester Avenue (60% interest in consolidated JV)(2) | Seaport Innovation District/ Greater Boston | 1/30/24 | — | N/A | 1,040,000 | — | $155,321 | ||||||||
428 Westlake Avenue North | Lake Union/Seattle | 10/1/24 | 1 | 100% | — | 90,626 | 47,600 | ||||||||
Other | 46,490 | ||||||||||||||
Total 2024 acquisitions | $249,411 |
Property | Submarket/Market | Date of Sale | Interest Sold | RSF | Capitalization Rate | Capitalization Rate (Cash Basis) | Sales Price | Seller Financing(1) | Sales Price per RSF | Gain on Sale of Real Estate(2) | ||||||||||||||
Stabilized Properties | ||||||||||||||||||||||||
One Moderna Way | Route 128/Greater Boston | 12/17/24 | 100% | 722,130 | 8.5% | 6.3% | $369,439 | $512 | $— | |||||||||||||||
1165 Eastlake Avenue East | Lake Union/Seattle | 9/12/24 | 100% | 100,086 | 4.7% | 4.9% | 149,985 | $1,499 | 21,535 | |||||||||||||||
14225 Newbrook Drive | Northern Virginia/Maryland | 10/15/24 | 100% | 248,186 | 7.6% | 7.4% | 80,500 | $324 | 37,074 | |||||||||||||||
6040 George Watts Hill Drive | Research Triangle/Research Triangle | 12/10/24 | 100% | 149,585 | 8.0% | 7.1% | 93,500 | $625 | 5,004 | |||||||||||||||
Other | 90,121 | 9,621 | ||||||||||||||||||||||
783,545 | ||||||||||||||||||||||||
Properties with vacancy or significant near-term capital requirements | ||||||||||||||||||||||||
215 First Street | Cambridge/Greater Boston | 12/20/24 | 100% | 369,520 | (3) | (3) | 245,539 | (3) | (3) | — | ||||||||||||||
150 Second Street, and 11 Hurley Street | Cambridge/Greater Boston | 182,993 | ||||||||||||||||||||||
4755 and 4757 Nexus Center Drive and 4796 Executive Drive(4) | University Town Center/San Diego | 12/30/24 | 100% | 177,804 | (4) | (4) | 120,000 | (4) | $79,166 | $675 | 47,511 | |||||||||||||
219 East 42nd Street | New York City/New York City | 7/9/24 | 100% | 349,947 | N/A | N/A | 60,000 | $171 | — | |||||||||||||||
Other | 51,106 | 392 | ||||||||||||||||||||||
476,645 | ||||||||||||||||||||||||
Land and other | ||||||||||||||||||||||||
99 A Street | Seaport Innovation District/ Greater Boston | 3/8/24 | 100% | 235,000 | (5) | (5) | 13,350 | — | ||||||||||||||||
10048 and 10219 Meanley Drive and 10277 Scripps Ranch Boulevard | Sorrento Mesa/San Diego | 12/20/24 | 100% | 444,041 | (5) | (5) | 55,000 | 25,000 | — | |||||||||||||||
9444 Waples Street (50% consolidated JV) | Sorrento Mesa/San Diego | 12/23/24 | (6) | 149,000 | (6) | (6) | 31,000 | (6) | 8,175 | (6) | ||||||||||||||
Other(7) | (7) | 22,913 | (7) | (7) | ||||||||||||||||||||
122,263 | ||||||||||||||||||||||||
Total 2024 dispositions | $1,382,453 | $104,166 | $129,312 | |||||||||||||||||||||
Our share of 2024 dispositions, including amounts recognized in equity in earnings | $1,366,953 | $127,615 | (8) | |||||||||||||||||||||
2024 | 4Q24 | ||
$118M | $55M | ||
1.5M RSF | 602,593 RSF | ||
98% Occupied |
2025 | 1Q26–2Q28 | ||
$83M | $312M | ||
89% Leased/Negotiating | |||
Aggregating 4.4M RSF |
500 North Beacon Street and 4 Kingsbury Avenue(1) | 201 Brookline Avenue | 840 Winter Street | ||
Greater Boston/ Cambridge/Inner Suburbs | Greater Boston/Fenway | Greater Boston/Route 128 | ||
211,574 RSF | 512,749 RSF | 139,984 RSF | ||
100% Occupancy | 98% Occupancy | 100% Occupancy | ||
![]() | ![]() | ![]() |
10935, 10945, and 10955 Alexandria Way(2) | 4155 Campus Point Court | 9808 Medical Center Drive | ||
San Diego/Torrey Pines | San Diego/ University Town Center | Maryland/Rockville | ||
93,492 RSF | 171,102 RSF | 95,061 RSF | ||
100% Occupancy | 100% Occupancy | 69% Occupancy | ||
![]() | ![]() | ![]() |
Property/Market/Submarket | 4Q24 Delivery Date(1) | Our Ownership Interest | RSF Placed in Service | Occupancy Percentage(2) | Total Project | Unlevered Yields | ||||||||||||||||||||||||||
Prior to 1/1/24 | 1Q24 | 2Q24 | 3Q24 | 4Q24 | Total | Initial Stabilized | Initial Stabilized (Cash Basis) | |||||||||||||||||||||||||
RSF | Investment | |||||||||||||||||||||||||||||||
Development projects | ||||||||||||||||||||||||||||||||
99 Coolidge Avenue/Greater Boston/ Cambridge/Inner Suburbs | N/A | 75.0% | 43,568 | 72,846 | — | — | — | 116,414 | 100% | 320,809 | $468,000 | 7.1% | 7.0% | |||||||||||||||||||
500 North Beacon Street and 4 Kingsbury Avenue/Greater Boston/Cambridge/Inner Suburbs | 11/1/24 | 100% | — | 100,624 | 37,913 | — | 73,037 | 211,574 | 100% | 248,018 | 427,000 | 6.2 | 5.5 | |||||||||||||||||||
201 Brookline Avenue/Greater Boston/ Fenway | 10/30/24 | 99.0% | 451,967 | — | — | — | 60,782 | 512,749 | 98% | 512,749 | 787,000 | 7.3 | 6.6 | |||||||||||||||||||
10935, 10945, and 10955 Alexandria Way/ San Diego/Torrey Pines | 11/1/24 | 100% | — | — | — | — | 93,492 | 93,492 | 100% | 334,996 | 503,000 | 6.2 | 5.8 | |||||||||||||||||||
4155 Campus Point Court/San Diego/ University Town Center | 11/7/24 | 55.0% | — | — | — | — | 171,102 | 171,102 | 100% | 171,102 | 184,000 | 8.0 | 6.4 | |||||||||||||||||||
1150 Eastlake Avenue East/Seattle/Lake Union | N/A | 100% | 278,282 | — | 2,079 | 31,270 | — | 311,631 | 100% | 311,631 | 442,000 | 6.6 | 6.7 | |||||||||||||||||||
9810 Darnestown Road/Maryland/Rockville | N/A | 100% | — | — | 195,435 | — | — | 195,435 | 100% | 195,435 | 135,000 | 7.1 | 6.2 | |||||||||||||||||||
9820 Darnestown Road/Maryland/Rockville | N/A | 100% | — | — | — | 250,000 | — | 250,000 | 100% | 250,000 | 177,000 | 8.7 | 5.6 | |||||||||||||||||||
9808 Medical Center Drive/Maryland/ Rockville | 12/31/24 | 100% | 26,460 | — | 25,655 | 13,056 | 29,890 | 95,061 | 69% | 95,061 | 114,000 | 5.4 | 5.4 | |||||||||||||||||||
Redevelopment projects | ||||||||||||||||||||||||||||||||
840 Winter Street/Greater Boston/Route 128 | 11/22/24 | 100% | — | — | — | — | 139,984 | 139,984 | 100% | 168,214 | 224,000 | 7.9 | (3) | 6.7 | (3) | |||||||||||||||||
651 Gateway Boulevard/San Francisco Bay Area/South San Francisco | N/A | 50.0% | — | 44,652 | — | 22,365 | — | 67,017 | 100% | 326,706 | 487,000 | 5.0 | 5.1 | |||||||||||||||||||
Alexandria Center® for Advanced Technologies – Monte Villa Parkway/ Seattle/Bothell | 12/31/24 | 100% | 65,086 | 115,598 | — | — | 34,306 | 214,990 | 90% | 460,934 | 216,000 | 6.3 | 6.2 | |||||||||||||||||||
Canada | N/A | 100% | 44,862 | 9,725 | 23,900 | — | — | 78,487 | 100% | 250,790 | 113,000 | 6.4 | 6.3 | |||||||||||||||||||
Weighted average/total | 11/7/24 | 910,225 | 343,445 | 284,982 | 316,691 | 602,593 | 2,457,936 | 3,646,445 | $4,277,000 | 6.7% | 6.2% | |||||||||||||||||||||
99 Coolidge Avenue | 500 North Beacon Street and 4 Kingsbury Avenue(1) | 311 Arsenal Street | 401 Park Drive | |||
Greater Boston/ Cambridge/Inner Suburbs | Greater Boston/ Cambridge/Inner Suburbs | Greater Boston/ Cambridge/Inner Suburbs | Greater Boston/Fenway | |||
204,395 RSF | 36,444 RSF | 308,446 RSF | 137,675 RSF | |||
62% Leased/Negotiating | 92% Leased/Negotiating | 21% Leased/Negotiating | —% Leased/Negotiating | |||
![]() | ![]() | ![]() | ![]() |
421 Park Drive | 40, 50, and 60 Sylvan Road | 1450 Owens Street | 651 Gateway Boulevard | |||
Greater Boston/Fenway | Greater Boston/Route 128 | San Francisco Bay Area/ Mission Bay | San Francisco Bay Area/ South San Francisco | |||
392,011 RSF | 596,064 RSF | 109,435 RSF | 259,689 RSF | |||
13% Leased/Negotiating | 31% Leased/Negotiating(2) | —% Leased/Negotiating(3) | 21% Leased/Negotiating | |||
![]() | ![]() | ![]() | ![]() |
230 Harriet Tubman Way | 269 East Grand Avenue | 10935, 10945, and 10955 Alexandria Way(1) | 4135 Campus Point Court | |||
San Francisco Bay Area/ South San Francisco | San Francisco Bay Area/ South San Francisco | San Diego/Torrey Pines | San Diego/ University Town Center | |||
285,346 RSF | 107,250 RSF | 241,504 RSF | 426,927 RSF | |||
100% Leased | —% Leased/Negotiating | 100% Leased | 100% Leased | |||
![]() | ![]() | ![]() | ![]() |
10075 Barnes Canyon Road | 701 Dexter Avenue North | 8800 Technology Forest Place | ||
San Diego/Sorrento Mesa | Seattle/Lake Union | Texas/Greater Houston | ||
253,079 RSF | 227,577 RSF | 73,298 RSF | ||
70% Leased/Negotiating | —% Leased/Negotiating | 41% Leased/Negotiating | ||
![]() | ![]() | ![]() |
Property/Market/Submarket | Square Footage | Percentage | Occupancy(1) | |||||||||||||||||
Dev/Redev | In Service | CIP | Total | Leased | Leased/ Negotiating | Initial | Stabilized | |||||||||||||
Under construction | ||||||||||||||||||||
2025 stabilization | ||||||||||||||||||||
500 North Beacon Street and 4 Kingsbury Avenue/Greater Boston/ Cambridge/Inner Suburbs | Dev | 211,574 | 36,444 | 248,018 | 92% | 92% | 1Q24 | 2025 | ||||||||||||
230 Harriet Tubman Way/San Francisco Bay Area/South San Francisco | Dev | — | 285,346 | 285,346 | 100 | 100 | 1Q25 | 1Q25 | ||||||||||||
Canada | Redev | 111,479 | 139,311 | 250,790 | 73 | 75 | 3Q23 | 2025 | ||||||||||||
323,053 | 461,101 | 784,154 | 89 | 89 | ||||||||||||||||
2026 and beyond stabilization | ||||||||||||||||||||
One Hampshire Street/Greater Boston/Cambridge | Redev | — | 104,956 | 104,956 | — | — | 2027 | 2028 | ||||||||||||
311 Arsenal Street/Greater Boston/Cambridge/Inner Suburbs | Redev | 82,216 | (2) | 308,446 | 390,662 | 21 | 21 | 2027 | 2027 | |||||||||||
99 Coolidge Avenue/Greater Boston/Cambridge/Inner Suburbs | Dev | 116,414 | 204,395 | 320,809 | 40 | 62 | 4Q23 | 2026 | ||||||||||||
401 Park Drive/Greater Boston/Fenway(3) | Redev | — | 137,675 | 137,675 | — | — | 2026 | 2026 | ||||||||||||
421 Park Drive/Greater Boston/Fenway | Dev | — | 392,011 | 392,011 | 13 | 13 | 2026 | 2027 | ||||||||||||
40, 50, and 60 Sylvan Road/Greater Boston/Route 128 | Redev | — | 596,064 | 596,064 | 31 | 31 | 2026 | 2027 | ||||||||||||
Other/Greater Boston | Redev | — | 453,869 | 453,869 | — | — | (4) | 2027 | 2027 | |||||||||||
1450 Owens Street/San Francisco Bay Area/Mission Bay | Dev | — | 109,435 | 109,435 | — | — | (5) | 2026 | 2026 | |||||||||||
651 Gateway Boulevard/San Francisco Bay Area/South San Francisco | Redev | 67,017 | 259,689 | 326,706 | 21 | 21 | 1Q24 | 2027 | ||||||||||||
269 East Grand Avenue/San Francisco Bay Area/South San Francisco | Redev | — | 107,250 | 107,250 | — | — | 2026 | 2027 | ||||||||||||
10935, 10945, and 10955 Alexandria Way/San Diego/Torrey Pines | Dev | 93,492 | 241,504 | 334,996 | 100 | 100 | 4Q24 | 2026 | ||||||||||||
4135 Campus Point Court/San Diego/University Town Center | Dev | — | 426,927 | 426,927 | 100 | 100 | 2026 | 2026 | ||||||||||||
10075 Barnes Canyon Road/San Diego/Sorrento Mesa | Dev | — | 253,079 | 253,079 | 70 | 70 | 2025 | 2026 | ||||||||||||
701 Dexter Avenue North/Seattle/Lake Union | Dev | — | 227,577 | 227,577 | — | — | 2026 | 2027 | ||||||||||||
8800 Technology Forest Place/Texas/Greater Houston | Redev | 50,094 | 73,298 | 123,392 | 41 | 41 | 2Q23 | 2026 | ||||||||||||
409,233 | 3,896,175 | 4,305,408 | 35 | 37 | ||||||||||||||||
732,286 | 4,357,276 | 5,089,562 | 43% | 45% | ||||||||||||||||
(1)Initial occupancy dates are subject to leasing and/or market conditions. Stabilized occupancy may vary depending on single tenancy versus multi-tenancy. Multi-tenant projects may increase in occupancy over a period of time. (2)We expect to redevelop an additional 25,312 RSF of space occupied as of December 31, 2024 into laboratory space upon expiration of the existing leases through the second half of 2025. Refer to “Investments in real estate” under “Definitions and reconciliations” in Item 7 for additional information. (3)During the three months ended December 31, 2024, we shifted the strategy of our 401 Park Drive redevelopment project to focus on the largest, most significant phase of the project. This phase aggregated 137,675 RSF and is expected to initially deliver and stabilize in 2026. Accordingly, we placed the less significant portion of the project that aggregated 22,284 RSF back into operations. (4)Represents a project focused on demand from our existing tenants in our adjacent properties/campuses that will address demand from other non-Alexandria properties/campuses. (5)Represents a multi-tenant project expanding our existing Alexandria Center® for Science and Technology – Mission Bay Megacampus, where our joint venture partner will fund 100% of the construction cost until it attains an ownership interest of 75%, after which it will contribute its respective share of additional capital. During the three months ended December 31, 2024, we executed a letter of intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project, with the transaction expected to close in 2025. Accordingly, we adjusted the development project RSF and its related book value to reflect 109,435 RSF, with our ownership share expected to be 25% at completion of the project. |
Our Ownership Interest | At 100% | Unlevered Yields | |||||||||||||||||
Property/Market/Submarket | In Service | CIP | Cost to Complete | Total at Completion | Initial Stabilized | Initial Stabilized (Cash Basis) | |||||||||||||
Under construction | |||||||||||||||||||
2025 stabilization | |||||||||||||||||||
500 North Beacon Street and 4 Kingsbury Avenue/Greater Boston/ Cambridge/Inner Suburbs | 100% | $378,021 | $37,026 | $11,953 | $427,000 | 6.2% | 5.5% | ||||||||||||
230 Harriet Tubman Way/San Francisco Bay Area/South San Francisco | 48.2% | — | 404,591 | 105,409 | 510,000 | 7.4% | 6.4% | ||||||||||||
Canada | 100% | 50,235 | 51,596 | 11,169 | 113,000 | 6.4% | 6.3% | ||||||||||||
428,256 | 493,213 | ||||||||||||||||||
2026 and beyond stabilization(1) | |||||||||||||||||||
One Hampshire Street/Greater Boston/Cambridge | 100% | — | 164,957 | TBD | |||||||||||||||
311 Arsenal Street/Greater Boston/Cambridge/Inner Suburbs | 100% | 60,649 | 240,342 | ||||||||||||||||
99 Coolidge Avenue/Greater Boston/Cambridge/Inner Suburbs | 75.0% | 136,635 | 196,917 | 134,448 | 468,000 | 7.1% | 7.0% | ||||||||||||
401 Park Drive/Greater Boston/Fenway | 100% | — | 151,301 | TBD | |||||||||||||||
421 Park Drive/Greater Boston/Fenway | 99.8% | — | 463,079 | ||||||||||||||||
40, 50, and 60 Sylvan Road/Greater Boston/Route 128 | 100% | — | 449,484 | ||||||||||||||||
Other/Greater Boston | 100% | — | 151,464 | ||||||||||||||||
1450 Owens Street/San Francisco Bay Area/Mission Bay | 25.1% | — | 121,957 | ||||||||||||||||
651 Gateway Boulevard/San Francisco Bay Area/South San Francisco | 50.0% | 87,376 | 258,708 | 140,916 | 487,000 | 5.0% | 5.1% | ||||||||||||
269 East Grand Avenue/San Francisco Bay Area/South San Francisco | 100% | — | 66,184 | TBD | |||||||||||||||
10935, 10945, and 10955 Alexandria Way/San Diego/Torrey Pines | 100% | 100,944 | 323,993 | 78,063 | 503,000 | 6.2% | 5.8% | ||||||||||||
4135 Campus Point Court/San Diego/University Town Center | 55.0% | — | 347,039 | 176,961 | 524,000 | 6.6% | 6.2% | ||||||||||||
10075 Barnes Canyon Road/San Diego/Sorrento Mesa | 50.0% | — | 183,733 | 137,267 | 321,000 | 5.5% | 5.7% | ||||||||||||
701 Dexter Avenue North/Seattle/Lake Union | 100% | — | 234,908 | TBD | |||||||||||||||
8800 Technology Forest Place/Texas/Greater Houston | 100% | 59,794 | 46,278 | 5,928 | 112,000 | 6.3% | 6.0% | ||||||||||||
445,398 | 3,400,344 | ||||||||||||||||||
$873,654 | $3,893,557 | $2,740,000 | (2) | $7,510,000 | (2) | ||||||||||||||
Our share of investment(2)(3) | $800,000 | $3,180,000 | $2,400,000 | $6,380,000 | |||||||||||||||
Refer to “Initial stabilized yield (unlevered)” under “Definitions and reconciliations” in Item 7 for additional information. (1)We expect to provide total estimated costs and related yields for each project with estimated stabilization in 2026 and beyond over the next several quarters. (2)Represents dollar amount rounded to the nearest $10 million and includes preliminary estimated amounts for projects listed as TBD. (3)Represents our share of investment based on our ownership percentage upon completion of development or redevelopment projects. |
Market Property/Submarket | Our Ownership Interest | Book Value | Square Footage | ||||||||||
Development and Redevelopment | Total(1) | ||||||||||||
Future Opportunities Subject to Market Conditions and Leasing | |||||||||||||
Under Construction | Priority Anticipated | Future | |||||||||||
Greater Boston | |||||||||||||
Megacampus: Alexandria Center® at One Kendall Square/Cambridge | 100% | $164,957 | 104,956 | — | — | 104,956 | |||||||
One Hampshire Street | |||||||||||||
Megacampus: The Arsenal on the Charles/Cambridge/Inner Suburbs | 100% | 288,993 | 344,890 | 25,312 | 34,157 | 404,359 | |||||||
311 Arsenal Street, 500 North Beacon Street, and 4 Kingsbury Avenue | |||||||||||||
Megacampus: 480 Arsenal Way and 446, 458, 500, and 550 Arsenal Street, and 99 Coolidge Avenue/Cambridge/Inner Suburbs | (2) | 285,870 | 204,395 | — | 902,000 | 1,106,395 | |||||||
446, 458, 500, and 550 Arsenal Street, and 99 Coolidge Avenue | |||||||||||||
Megacampus: Alexandria Center® for Life Science – Fenway/Fenway | (3) | 614,380 | 529,686 | — | — | 529,686 | |||||||
401 and 421 Park Drive | |||||||||||||
Megacampus: Alexandria Center® for Life Science – Waltham/Route 128 | 100% | 512,996 | 596,064 | — | 515,000 | 1,111,064 | |||||||
40, 50, and 60 Sylvan Road, and 35 Gatehouse Drive | |||||||||||||
Megacampus: Alexandria Center® at Kendall Square/Cambridge | 100% | 204,128 | — | — | 174,500 | 174,500 | |||||||
100 Edwin H. Land Boulevard | |||||||||||||
Megacampus: Alexandria Technology Square®/Cambridge | 100% | 7,907 | — | — | 100,000 | 100,000 | |||||||
Megacampus: 285, 299, 307, and 345 Dorchester Avenue/Seaport Innovation District | 60.0% | 288,527 | — | — | 1,040,000 | 1,040,000 | |||||||
10 Necco Street/Seaport Innovation District | 100% | 105,106 | — | — | 175,000 | 175,000 | |||||||
215 Presidential Way/Route 128 | 100% | 6,816 | — | — | 112,000 | 112,000 | |||||||
Other development and redevelopment projects | (4) | 405,145 | 453,869 | — | 1,365,496 | 1,819,365 | |||||||
$2,884,825 | 2,233,860 | 25,312 | 4,418,153 | 6,677,325 | |||||||||
Refer to “Megacampus” under “Definitions and reconciliations” in Item 7 for additional information. (1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to “Investments in real estate” under “Definitions and reconciliations” in Item 7 for additional information, including development and redevelopment square feet currently included in rental properties. (2)We have a 75.0% interest in 99 Coolidge Avenue aggregating 204,395 RSF and a 100% interest in 446, 458, 500, and 550 Arsenal Street aggregating 902,000 RSF. (3)We have a 100% interest in 401 Park Drive aggregating 137,675 RSF and a 99.8% interest in 421 Park Drive aggregating 392,011 RSF. (4)Includes a property in which we own a partial interest through a real estate joint venture. | |||||||||||||
Market Property/Submarket | Our Ownership Interest | Book Value | Square Footage | ||||||||||
Development and Redevelopment | Total(1) | ||||||||||||
Future Opportunities Subject to Market Conditions and Leasing | |||||||||||||
Under Construction | Priority Anticipated | Future | |||||||||||
San Francisco Bay Area | |||||||||||||
Megacampus: Alexandria Center® for Science and Technology – Mission Bay/ Mission Bay | 25.1% | $121,957 | (2) | 109,435 | (2) | — | — | 109,435 | |||||
1450 Owens Street | |||||||||||||
Alexandria Center® for Life Science – Millbrae/South San Francisco | 48.2% | 568,776 | 285,346 | 198,188 | 150,213 | 633,747 | |||||||
230 Harriet Tubman Way, 201 and 231 Adrian Road, and 6 and 30 Rollins Road | |||||||||||||
Megacampus: Alexandria Technology Center® – Gateway/South San Francisco | 50.0% | 285,334 | 259,689 | — | 291,000 | 550,689 | |||||||
651 Gateway Boulevard | |||||||||||||
Megacampus: Alexandria Center® for Advanced Technologies – South San Francisco/South San Francisco | 100% | 72,839 | 107,250 | — | 90,000 | 197,250 | |||||||
211(3) and 269 East Grand Avenue | |||||||||||||
Megacampus: Alexandria Center® for Advanced Technologies – Tanforan/South San Francisco | 100% | 406,586 | — | — | 1,930,000 | 1,930,000 | |||||||
1122, 1150, and 1178 El Camino Real | |||||||||||||
Megacampus: Alexandria Center® for Life Science – San Carlos/Greater Stanford | 100% | 455,849 | — | — | 1,497,830 | 1,497,830 | |||||||
960 Industrial Road, 987 and 1075 Commercial Street, and 888 Bransten Road | |||||||||||||
3825 and 3875 Fabian Way/Greater Stanford | 100% | 156,602 | — | — | 478,000 | 478,000 | |||||||
2100, 2200, 2300, and 2400 Geng Road/Greater Stanford | 100% | 37,264 | — | — | 240,000 | 240,000 | |||||||
Megacampus: 88 Bluxome Street/SoMa | 100% | 397,952 | — | — | 1,070,925 | 1,070,925 | |||||||
Other development and redevelopment projects | 100% | — | — | — | 56,924 | 56,924 | |||||||
$2,503,159 | 761,720 | 198,188 | 5,804,892 | 6,764,800 | |||||||||
Refer to “Megacampus” under “Definitions and reconciliations” in Item 7 for additional information. (1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to “Investments in real estate” under “Definitions and reconciliations” in Item 7 for additional information, including development and redevelopment square feet currently included in rental properties. (2)During the three months ended December 31, 2024, we executed a letter of intent with a biomedical institution for the sale of a condominium interest aggregating 103,361 RSF, or approximately 49% of the development project, with the transaction expected to close in 2025. Accordingly, we adjusted the development project RSF and its related book value to reflect 109,435 RSF, with our ownership share expected to be 25% at completion of the project. (3)We own a partial interest in this property through a real estate joint venture. Refer to Note 4 – “Consolidated and unconsolidated real estate joint ventures” to our consolidated financial statements in Item 15 for additional details. | |||||||||||||
Market Property/Submarket | Our Ownership Interest | Book Value | Square Footage | ||||||||||
Development and Redevelopment | Total(1) | ||||||||||||
Future Opportunities Subject to Market Conditions and Leasing | |||||||||||||
Under Construction | Priority Anticipated | Future | |||||||||||
San Diego | |||||||||||||
Megacampus: One Alexandria Square/Torrey Pines | 100% | $382,913 | 241,504 | — | 125,280 | 366,784 | |||||||
10935 and 10945 Alexandria Way and 10975 and 10995 Torreyana Road | |||||||||||||
Megacampus: Campus Point by Alexandria/University Town Center | 55.0% | 492,221 | 426,927 | 333,414 | 634,043 | 1,394,384 | |||||||
10010(2), 10140(2), 10210, and 10260 Campus Point Drive and 4135, 4161, 4165, and 4224 Campus Point Court | |||||||||||||
Megacampus: SD Tech by Alexandria/Sorrento Mesa | 50.0% | 346,929 | 253,079 | 250,000 | 243,845 | 746,924 | |||||||
9805 Scranton Road and 10075 Barnes Canyon Road | |||||||||||||
11255 and 11355 North Torrey Pines Road/Torrey Pines | 100% | 153,104 | — | 153,000 | 62,000 | 215,000 | |||||||
Megacampus: 5200 Illumina Way/University Town Center | 51.0% | 17,443 | — | — | 451,832 | 451,832 | |||||||
9625 Towne Centre Drive/University Town Center | 30.0% | 837 | — | — | 100,000 | 100,000 | |||||||
Megacampus: Sequence District by Alexandria/Sorrento Mesa | 100% | 46,323 | — | — | 1,798,915 | 1,798,915 | |||||||
6260, 6290, 6310, 6340, 6350, and 6450 Sequence Drive | |||||||||||||
Scripps Science Park by Alexandria/Sorrento Mesa | 100% | 42,417 | — | — | 154,308 | 154,308 | |||||||
10256 and 10260 Meanley Drive | |||||||||||||
4075 Sorrento Valley Boulevard/Sorrento Valley | 100% | 19,130 | — | — | 144,000 | 144,000 | |||||||
Other development and redevelopment projects | (3) | 76,843 | — | — | 475,000 | 475,000 | |||||||
$1,578,160 | 921,510 | 736,414 | 4,189,223 | 5,847,147 | |||||||||
Refer to “Megacampus” under “Definitions and reconciliations” in Item 7 for additional information. (1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes RSF of buildings currently in operation at properties that also have inherent future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property subject to market conditions and leasing. Refer to “Investments in real estate” under “Definitions and reconciliations” in Item 7 for additional information, including development and redevelopment square feet currently included in rental properties. (2)We have a 100% interest in this property. (3)Includes a property in which we own a partial interest through a real estate joint venture. |
Market Property/Submarket | Our Ownership Interest | Book Value | Square Footage | ||||||||||
Development and Redevelopment | Total(1) | ||||||||||||
Future Opportunities Subject to Market Conditions and Leasing | |||||||||||||
Under Construction | Priority Anticipated | Future | |||||||||||
Seattle | |||||||||||||
Megacampus: Alexandria Center® for Life Science – South Lake Union/Lake Union | (2) | $516,743 | 227,577 | 869,000 | 188,400 | 1,284,977 | |||||||
601 and 701 Dexter Avenue North and 800 Mercer Street | |||||||||||||
1010 4th Avenue South/SoDo | 100% | 59,996 | — | — | 544,825 | 544,825 | |||||||
410 West Harrison Street/Elliott Bay | 100% | — | — | — | 91,000 | 91,000 | |||||||
Megacampus: Alexandria Center® for Advanced Technologies – Canyon Park/ Bothell | 100% | 18,066 | — | — | 230,000 | 230,000 | |||||||
21660 20th Avenue Southeast | |||||||||||||
Other development and redevelopment projects | 100% | 144,644 | — | — | 706,087 | 706,087 | |||||||
739,449 | 227,577 | 869,000 | 1,760,312 | 2,856,889 | |||||||||
Maryland | |||||||||||||
Megacampus: Alexandria Center® for Life Science – Shady Grove/Rockville | 100% | 22,593 | — | — | 296,000 | 296,000 | |||||||
9830 Darnestown Road | |||||||||||||
22,593 | — | — | 296,000 | 296,000 | |||||||||
Research Triangle | |||||||||||||
Megacampus: Alexandria Center® for Advanced Technologies and Agtech – Research Triangle/Research Triangle | 100% | 106,906 | — | 180,000 | 990,000 | 1,170,000 | |||||||
4 and 12 Davis Drive | |||||||||||||
Megacampus: Alexandria Center® for Life Science – Durham/Research Triangle | 100% | 158,277 | — | — | 2,060,000 | 2,060,000 | |||||||
Megacampus: Alexandria Center® for NextGen Medicines/Research Triangle | 100% | 109,368 | — | — | 1,055,000 | 1,055,000 | |||||||
3029 East Cornwallis Road | |||||||||||||
Megacampus: Alexandria Center® for Sustainable Technologies/Research Triangle | 100% | 53,941 | — | — | 750,000 | 750,000 | |||||||
120 TW Alexander Drive, 2752 East NC Highway 54, and 10 South Triangle Drive | |||||||||||||
100 Capitola Drive/Research Triangle | 100% | — | — | — | 65,965 | 65,965 | |||||||
Other development and redevelopment projects | 100% | 4,185 | — | — | 76,262 | 76,262 | |||||||
$432,677 | — | 180,000 | 4,997,227 | 5,177,227 | |||||||||
Refer to “Megacampus” under “Definitions and reconciliations” in Item 7 for additional information. (1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have inherent future development or redevelopment opportunities. Upon expiration of existing in-place leases, we have the intent to demolish or redevelop the existing property. Refer to “Investments in real estate” under “Definitions and reconciliations” in Item 7 for additional information, including development and redevelopment square feet currently included in rental properties. (2)We have a 100% interest in 601 and 701 Dexter Avenue North aggregating 415,977 RSF and a 60% interest in the priority anticipated development project at 800 Mercer Street aggregating 869,000 RSF. |
Market Property/Submarket | Our Ownership Interest | Book Value | Square Footage | ||||||||||
Development and Redevelopment | Total(1) | ||||||||||||
Future Opportunities Subject to Market Conditions and Leasing | |||||||||||||
Under Construction | Priority Anticipated | Future | |||||||||||
New York City | |||||||||||||
Megacampus: Alexandria Center® for Life Science – New York City/New York City | 100% | $168,423 | — | — | 550,000 | (2) | 550,000 | ||||||
168,423 | — | — | 550,000 | 550,000 | |||||||||
Texas | |||||||||||||
Alexandria Center® for Advanced Technologies at The Woodlands/Greater Houston | 100% | 49,118 | 73,298 | — | 116,405 | 189,703 | |||||||
8800 Technology Forest Place | |||||||||||||
1001 Trinity Street and 1020 Red River Street/Austin | 100% | 10,533 | — | 126,034 | 123,976 | 250,010 | |||||||
Other development and redevelopment projects | 100% | 56,798 | — | — | 344,000 | 344,000 | |||||||
116,449 | 73,298 | 126,034 | 584,381 | 783,713 | |||||||||
Canada | 100% | 51,596 | 139,311 | — | 371,743 | 511,054 | |||||||
Other development and redevelopment projects | 100% | 121,396 | — | — | 724,349 | 724,349 | |||||||
Total pipeline as of December 31, 2024, excluding properties held for sale | 8,618,727 | 4,357,276 | 2,134,948 | 23,696,280 | 30,188,504 | ||||||||
Properties held for sale | 237,739 | — | — | 2,390,856 | 2,390,856 | ||||||||
Total pipeline as of December 31, 2024 | $8,856,466 | (3) | 4,357,276 | 2,134,948 | 26,087,136 | 32,579,360 | |||||||
Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans | Approximate Value of Shares That May Yet Be Purchased Under Plans | |||||
December 9, 2024(1) - December 31, 2024 | 496,276 | $100.95 | 496,276 | $449,903,317 |
Year Ended December 31, | |||||
2024 | 2023 | ||||
Net income attributable to Alexandria’s common stockholders – diluted: | |||||
In millions | $309.6 | $92.4 | |||
Per share | $1.80 | $0.54 | |||
Funds from operations attributable to Alexandria’s common stockholders – diluted, as adjusted: | |||||
In millions | $1,629.1 | $1,532.3 | |||
Per share | $9.47 | $8.97 |
(As of December 31, 2024, unless stated otherwise) | ||||
Occupancy of operating properties in North America | 94.6% | |||
Percentage of total annual rental revenue in effect from Megacampus platform | 77% | |||
Percentage of total annual rental revenue in effect from investment-grade or publicly traded large cap tenants | 52% | |||
Adjusted EBITDA margin for the three months ended December 31, 2024 | 72% | |||
Percentage of leases containing annual rent escalations | 97% | |||
Weighted-average remaining lease term: | ||||
Top 20 tenants | 9.3 | years | ||
All tenants | 7.5 | years | ||
Sustained strength in tenant collections: | ||||
January 2025 tenant rents and receivables collected as of the date of this report | 99.5% | |||
Tenant rents and receivables for the three months ended December 31, 2024 collected as of the date of this report | 99.9% | |||
2024 | |||
Total leasing activity – RSF | 5,053,954 | ||
Leasing of development and redevelopment space – RSF | 493,341 | ||
Lease renewals and re-leasing of space: | |||
RSF (included in total leasing activity above) | 3,888,139 | ||
Rental rate increase | 16.9% | ||
Rental rate increase (cash basis) | 7.2% | ||
(in millions) | ||
During the nine months ended September 30, 2024 | $239 | |
During the three months ended December 31, 2024 | 1,128 | |
Total 2024 dispositions | $1,367 |
(dollars in millions) | Incremental Annual Net Operating Income | RSF | Occupancy Percentage | ||||
Placed into service: | |||||||
Nine months ended September 30, 2024 | $63 | 945,118 | 100% | ||||
Three months ended December 31, 2024 | 55 | 602,593 | 98 | ||||
Total placed into service in 2024 | $118 | 1,547,711 | 98% | ||||
Expected to be placed into service: | |||||||
Fiscal year 2025 | $83 | (1) | 4,357,276 | ||||
First quarter of 2026 through second quarter of 2028 | 312 | ||||||
$395 | |||||||
Tenant Improvements/ Leasing Commissions per RSF | Average Free Rent per Annum | |||
2022 | $27.83 | 0.3 months | ||
2023 | $26.09 | 0.6 months | ||
2024 | $46.89 | 0.7 months |
Total Dispositions and Sales of Partial Interests | Gains on Sales of Real Estate | Consideration in Excess of Book Value | Real Estate Impairment | Capitalization Rates(1) | Capitalization Rates (cash basis)(1) | ||||||||
2022 | $2,222,296 | $537,918 | $644,029 | $64,969 | 4.5% | 4.4% | |||||||
2023 | $1,314,414 | $277,037 | $7,792 | $461,114 | 6.7% | 5.9% | |||||||
2024 | $1,382,453 | $129,312 | $— | $223,068 | 7.7% | 6.5% |
Unsecured Senior Notes Payable Issued | Interest Rate(1) | |||
2022 | $1,800,000 | 3.38% | ||
2023 | $1,000,000 | 5.07% | ||
2024 | $1,000,000 | 5.57% |
Gross Interest Expense | Capitalized Interest | Interest Expense | ||||
2022 | $372,848 | $(278,645) | $94,203 | |||
2023 | $438,182 | $(363,978) | $74,204 | |||
2024 | $516,799 | $(330,961) | $185,838 |
Realized Gains(1) | Unrealized Losses | Total Investment Loss | ||||
2022 | $80,435 | $(412,193) | $(331,758) | |||
2023 | $6,078 | $(201,475) | $(195,397) | |||
2024 | $59,124 | $(112,246) | $(53,122) | |||
Same Property Net Operating Income Growth | Rental Rate Growth: Renewed/Re-Leased Space | |||||||||
Margins(1) | Favorable Lease Structure(2) | |||||||||
Operating | Adjusted EBITDA | Strategic Lease Structure by Owner and Operator of Collaborative Megacampus Ecosystems | ||||||||
70% | 72% | Increasing cash flows | ||||||||
Percentage of leases containing annual rent escalations | 97% | |||||||||
Stable cash flows | ||||||||||
Weighted-Average Lease Term of Executed Leases(3) | Percentage of triple net leases | 92% | ||||||||
Lower capex burden | ||||||||||
8.9 Years | Percentage of leases providing for the recapture of capital expenditures | 92% | ||||||||
Net Debt and Preferred Stock to Adjusted EBITDA(4) | Fixed-Charge Coverage Ratio(4) | |||||||||
Year Ended December 31, | |||||||
2024 | 2023 | 2024 | 2023 | ||||
Amount | Per Share – Diluted | ||||||
Unrealized losses on non-real estate investments | $(112.2) | $(201.5) | $(0.65) | $(1.18) | |||
Gain on sales of real estate(1) | 129.3 | 277.0 | 0.75 | 1.62 | |||
Impairment of non-real estate investments | (58.1) | (74.6) | (0.34) | (0.44) | |||
Impairment of real estate | (223.1) | (461.1) | (1.30) | (2.70) | |||
Acceleration of stock compensation expense due to executive officer resignations | — | (20.3) | — | (0.12) | |||
Provision for expected credit losses on financial instruments | 0.4 | — | — | — | |||
Total | $(263.7) | $(480.5) | $(1.54) | $(2.82) |
December 31, | ||||
2024 | 2023 | |||
Percentage change in net operating income over comparable period from prior year | 1.2% | 3.4% | ||
Percentage change in net operating income (cash basis) over comparable period from prior year | 4.6% | 4.6% | ||
Operating margin | 68% | 69% | ||
Number of Same Properties | 321 | 288 | ||
RSF | 31,670,359 | 28,691,105 | ||
Occupancy – current-period average | 94.2% | 94.6% | ||
Occupancy – same-period prior-year average | 93.9% | 95.4% |
Development – under construction | Properties | ||
99 Coolidge Avenue | 1 | ||
500 North Beacon Street and 4 Kingsbury Avenue | 2 | ||
1450 Owens Street | 1 | ||
230 Harriet Tubman Way | 1 | ||
10935, 10945, and 10955 Alexandria Way | 3 | ||
10075 Barnes Canyon Road | 1 | ||
421 Park Drive | 1 | ||
4135 Campus Point Court | 1 | ||
701 Dexter Avenue North | 1 | ||
12 | |||
Development – placed into service after January 1, 2023 | Properties | ||
751 Gateway Boulevard | 1 | ||
15 Necco Street | 1 | ||
325 Binney Street | 1 | ||
9810 Darnestown Road | 1 | ||
9820 Darnestown Road | 1 | ||
1150 Eastlake Avenue East | 1 | ||
4155 Campus Point Court | 1 | ||
201 Brookline Avenue | 1 | ||
9808 Medical Center Drive | 1 | ||
9 | |||
Redevelopment – under construction | Properties | ||
40, 50, and 60 Sylvan Road | 3 | ||
269 East Grand Avenue | 1 | ||
651 Gateway Boulevard | 1 | ||
401 Park Drive | 1 | ||
8800 Technology Forest Place | 1 | ||
311 Arsenal Street | 1 | ||
One Hampshire Street | 1 | ||
Canada | 4 | ||
Other | 2 | ||
15 |
Redevelopment – placed into service after January 1, 2023 | Properties | ||
20400 Century Boulevard | 1 | ||
140 First Street | 1 | ||
2400 Ellis Road, 40 Moore Drive, and 14 TW Alexander Drive | 3 | ||
9601 and 9603 Medical Center Drive | 2 | ||
840 Winter Street | 1 | ||
Alexandria Center® for Advanced Technologies – Monte Villa Parkway | 6 | ||
14 | |||
Acquisitions after January 1, 2023 | Properties | ||
Other | 6 | ||
6 | |||
Unconsolidated real estate JVs | 4 | ||
Properties held for sale | 10 | ||
Total properties excluded from Same Properties | 70 | ||
Same Properties | 321 | ||
Total properties in North America as of December 31, 2024 | 391 | ||
Year Ended December 31, | |||||||||
2024 | 2023 | $ Change | % Change | ||||||
Income from rentals: | |||||||||
Same Properties | $1,685,654 | $1,640,232 | $45,422 | 2.8% | |||||
Non-Same Properties | 618,685 | 503,739 | 114,946 | 22.8 | |||||
Rental revenues | 2,304,339 | 2,143,971 | 160,368 | 7.5 | |||||
Same Properties | 612,600 | 598,442 | 14,158 | 2.4 | |||||
Non-Same Properties | 132,767 | 100,043 | 32,724 | 32.7 | |||||
Tenant recoveries | 745,367 | 698,485 | 46,882 | 6.7 | |||||
Income from rentals | 3,049,706 | 2,842,456 | 207,250 | 7.3 | |||||
Same Properties | 1,740 | 1,675 | 65 | 3.9 | |||||
Non-Same Properties | 64,948 | 41,568 | 23,380 | 56.2 | |||||
Other income | 66,688 | 43,243 | 23,445 | 54.2 | |||||
Same Properties | 2,299,994 | 2,240,349 | 59,645 | 2.7 | |||||
Non-Same Properties | 816,400 | 645,350 | 171,050 | 26.5 | |||||
Total revenues | 3,116,394 | 2,885,699 | 230,695 | 8.0 | |||||
Same Properties | 734,965 | 693,574 | 41,391 | 6.0 | |||||
Non-Same Properties | 174,300 | 165,606 | 8,694 | 5.2 | |||||
Rental operations | 909,265 | 859,180 | 50,085 | 5.8 | |||||
Same Properties | 1,565,029 | 1,546,775 | 18,254 | 1.2 | |||||
Non-Same Properties | 642,100 | 479,744 | 162,356 | 33.8 | |||||
Net operating income | $2,207,129 | $2,026,519 | $180,610 | 8.9% | |||||
Net operating income – Same Properties | $1,565,029 | $1,546,775 | $18,254 | 1.2% | |||||
Straight-line rent revenue | (31,326) | (85,412) | 54,086 | (63.3) | |||||
Amortization of acquired below-market leases | (44,683) | (37,985) | (6,698) | 17.6 | |||||
Net operating income – Same Properties (cash basis) | $1,489,020 | $1,423,378 | $65,642 | 4.6% |
Year Ended December 31, | ||||||
Component | 2024 | 2023 | Change | |||
Gross interest | $516,799 | $438,182 | $78,617 | |||
Capitalized interest | (330,961) | (363,978) | 33,017 | |||
Interest expense | $185,838 | $74,204 | $111,634 | |||
Average debt balance outstanding(1) | $12,583,339 | $11,242,532 | $1,340,807 | |||
Weighted-average annual interest rate(2) | 4.1% | 3.9% | 0.2% |
Component | Interest Rate(1) | Effective Date | Change | ||||||
Increases in interest incurred due to: | |||||||||
Issuances of debt: | |||||||||
$500 million of unsecured senior notes payable due 2053 | 5.26% | February 2023 | $3,226 | ||||||
$500 million of unsecured senior notes payable due 2035 | 4.88% | February 2023 | 2,984 | ||||||
$600 million of unsecured senior notes payable due 2054 | 5.71% | February 2024 | 29,634 | ||||||
$400 million of unsecured senior notes payable due 2036 | 5.38% | February 2024 | 18,483 | ||||||
Increases in construction borrowings and interest rates under secured notes payable | 7.52% | 3,882 | |||||||
Higher average outstanding balances and/or rate increases on borrowings under commercial paper program and unsecured senior line of credit | 17,747 | ||||||||
Other increase in interest | 2,661 | ||||||||
Change in gross interest | 78,617 | ||||||||
Decrease in capitalized interest | 33,017 | ||||||||
Total change in interest expense | $111,634 |
Year Ended December 31, 2024 | Projected Midpoint for the Year Ending December 31, 2025 | ||||||||
Construction of Class A/A+ properties: | |||||||||
Active construction projects | |||||||||
Under construction(1) | $ | 1,791,097 | $ | 1,220,000 | |||||
Future pipeline pre-construction | |||||||||
Primarily Megacampus expansion pre-construction work (entitlement, design, and site work) | 426,948 | 500,000 | |||||||
Revenue- and non-revenue-enhancing capital expenditures | 273,377 | 415,000 | (2) | ||||||
Construction spend (before contributions from noncontrolling interests or tenants) | 2,491,422 | 2,135,000 | |||||||
Contributions from noncontrolling interests (consolidated real estate joint ventures) | (343,797) | (230,000) | (3) | ||||||
Tenant-funded and -built landlord improvements | (129,153) | (155,000) | |||||||
Total construction spending | $ | 2,018,472 | $ | 1,750,000 | |||||
2025 guidance range for construction spending | $1,450,000 – $2,050,000 |
Projected timing | Amount(1) | |
Fiscal year 2025 | $230,000 | |
2026 through 2028 | 454,086 | |
Total | $684,086 |
Average Real Estate Basis Capitalized During the Year Ended December 31, 2024 | Percentage of Total Average Real Estate Basis Capitalized | |||||||
2024 | 2025(1) | |||||||
Construction of Class A/A+ properties: | ||||||||
Active construction projects | ||||||||
Under construction | $2,924,369 | 36% | 35% | |||||
Future pipeline pre-construction | ||||||||
Priority anticipated projects | 508,108 | (2) | 6 | 50 | ||||
Primarily Megacampus expansion pre-construction work (entitlement, design, and site work) | 3,710,741 | (2) | 46 | |||||
Smaller redevelopments and repositioning capital projects | 981,589 | 12 | 15 | |||||
$8,124,807 | 100% | 100% | ||||||
Projected 2025 Earnings per Share and Funds From Operations per Share Attributable to Alexandria’s Common Stockholders – Diluted | ||||
Earnings per share(1) | $2.57 to $2.77 | |||
Depreciation and amortization of real estate assets | 6.70 | |||
Allocation of unvested restricted stock awards | (0.04) | |||
Funds from operations per share and funds from operations per share, as adjusted(2) | $9.23 to $9.43 | |||
Midpoint | $9.33 | |||
Key Assumptions(1) (Dollars in millions) | 2025 Guidance | ||||
Low | High | ||||
Occupancy percentage for operating properties in North America as of December 31, 2025 | 91.6% | 93.2% | |||
Lease renewals and re-leasing of space: | |||||
Rental rate changes | 9.0% | 17.0% | |||
Rental rate changes (cash basis) | 0.5% | 8.5% | |||
Same property performance: | |||||
Net operating income | (3.0)% | (1.0)% | |||
Net operating income (cash basis) | (1.0)% | 1.0% | |||
Straight-line rent revenue | $111 | $131 | |||
General and administrative expenses | $129 | $144 | |||
Capitalization of interest | $340 | $370 | |||
Interest expense | $165 | $195 | |||
Realized gains on non-real estate investments(2) | $100 | $130 | |||
Key Credit Metric Targets(1) | |||
Net debt and preferred stock to Adjusted EBITDA – fourth quarter of 2025 annualized | Less than or equal to 5.2x | ||
Fixed-charge coverage ratio – fourth quarter of 2025 annualized | 4.0x to 4.5x | ||
Consolidated Real Estate Joint Ventures | ||||||||
Property/Market/Submarket | Noncontrolling(1) Interest Share | Operating RSF at 100% | ||||||
50 and 60 Binney Street/Greater Boston/Cambridge/Inner Suburbs | 66.0% | 532,395 | ||||||
75/125 Binney Street/Greater Boston/Cambridge/Inner Suburbs | 60.0% | 388,270 | ||||||
100 and 225 Binney Street and 300 Third Street/Greater Boston/Cambridge/Inner Suburbs | 70.0% | 870,106 | ||||||
99 Coolidge Avenue/Greater Boston/Cambridge/Inner Suburbs | 25.0% | 116,414 | (2) | |||||
15 Necco Street/Greater Boston/Seaport Innovation District | 43.3% | 345,996 | ||||||
285, 299, 307, and 345 Dorchester Avenue/Greater Boston/Seaport Innovation District | 40.0% | — | (2) | |||||
Alexandria Center® for Science and Technology – Mission Bay/San Francisco Bay Area/ Mission Bay(3) | 75.0% | 996,181 | ||||||
1450 Owens Street/San Francisco Bay Area/Mission Bay | 74.9% | (4) | — | (2) | ||||
601, 611, 651(2), 681, 685, and 701 Gateway Boulevard/San Francisco Bay Area/South San Francisco | 50.0% | 851,991 | ||||||
751 Gateway Boulevard/San Francisco Bay Area/South San Francisco | 49.0% | 230,592 | ||||||
211(2) and 213 East Grand Avenue/San Francisco Bay Area/South San Francisco | 70.0% | 300,930 | ||||||
500 Forbes Boulevard/San Francisco Bay Area/South San Francisco | 90.0% | 155,685 | ||||||
Alexandria Center® for Life Science – Millbrae/San Francisco Bay Area/South San Francisco | 51.8% | — | (2) | |||||
3215 Merryfield Row/San Diego/Torrey Pines | 70.0% | 170,523 | ||||||
Campus Point by Alexandria/San Diego/University Town Center(5) | 45.0% | 1,496,181 | ||||||
5200 Illumina Way/San Diego/University Town Center | 49.0% | 792,687 | ||||||
9625 Towne Centre Drive/San Diego/University Town Center | 70.0% | 163,648 | ||||||
SD Tech by Alexandria/San Diego/Sorrento Mesa(6) | 50.0% | 798,860 | ||||||
Pacific Technology Park/San Diego/Sorrento Mesa | 50.0% | 544,352 | ||||||
Summers Ridge Science Park/San Diego/Sorrento Mesa(7) | 70.0% | 316,531 | ||||||
1201 and 1208 Eastlake Avenue East/Seattle/Lake Union | 70.0% | 206,134 | ||||||
199 East Blaine Street/Seattle/Lake Union | 70.0% | 115,084 | ||||||
400 Dexter Avenue North/Seattle/Lake Union | 70.0% | 290,754 | ||||||
800 Mercer Street/Seattle/Lake Union | 40.0% | — | (2) | |||||
Unconsolidated Real Estate Joint Ventures | ||||||||
Property/Market/Submarket | Our Ownership Share(8) | Operating RSF at 100% | ||||||
1655 and 1725 Third Street/San Francisco Bay Area/Mission Bay | 10.0% | 586,208 | ||||||
1450 Research Boulevard/Maryland/Rockville | 73.2% | (9) | 42,679 | |||||
101 West Dickman Street/Maryland/Beltsville | 58.4% | (9) | 135,949 | |||||
Maturity Date | Stated Rate | Interest Rate(1) | At 100% | Our Share | ||||||||||
Unconsolidated Joint Venture | Aggregate Commitment | Debt Balance(2) | ||||||||||||
1655 and 1725 Third Street(3) | 3/10/25 | 4.50% | 4.57% | $600,000 | $599,930 | 10.0% | ||||||||
101 West Dickman Street | 11/10/26 | SOFR+1.95% | (4) | 6.36% | 26,750 | 18,884 | 58.4% | |||||||
1450 Research Boulevard | 12/10/26 | SOFR+1.95% | (4) | 6.42% | 13,000 | 8,637 | 73.2% | |||||||
$639,750 | $627,451 |
Noncontrolling Interest Share of Consolidated Real Estate Joint Ventures | Our Share of Unconsolidated Real Estate Joint Ventures | ||||||
December 31, 2024 | December 31, 2024 | ||||||
Three Months Ended | Year Ended | Three Months Ended | Year Ended | ||||
Total revenues | $112,690 | $448,476 | $6,282 | $15,754 | |||
Rental operations | (35,776) | (132,785) | (994) | (3,978) | |||
76,914 | 315,691 | 5,288 | 11,776 | ||||
General and administrative | (644) | (2,912) | (79) | (159) | |||
Interest | (361) | (1,114) | (841) | (3,648) | |||
Depreciation and amortization of real estate assets | (34,986) | (129,711) | (1,061) | (4,238) | |||
Gain on sales of real estate | 5,025 | 5,025 | 3,328 | 3,328 | |||
Fixed returns allocated to redeemable noncontrolling interests(1) | 202 | 805 | — | — | |||
$46,150 | $187,784 | $6,635 | $7,059 | ||||
Straight-line rent and below-market lease revenue | $(2,821) | $12,767 | $159 | $902 | |||
Funds from operations(2) | $76,111 | $312,470 | $4,368 | $7,969 |
As of December 31, 2024 | ||||
Noncontrolling Interest Share of Consolidated Real Estate Joint Ventures | Our Share of Unconsolidated Real Estate Joint Ventures | |||
Investments in real estate | $4,240,036 | $109,756 | ||
Cash, cash equivalents, and restricted cash | 163,799 | 3,218 | ||
Other assets | 416,997 | 10,019 | ||
Secured notes payable | (37,330) | (77,345) | ||
Other liabilities | (274,083) | (5,775) | ||
Redeemable noncontrolling interests | (19,972) | — | ||
$4,489,447 | $39,873 |
December 31, 2024 | Year Ended December 31, 2023 | ||||||||
Three Months Ended | Year Ended | ||||||||
Realized gains | $11,788 | (1) | $59,124 | (1) | $6,078 | (2) | |||
Unrealized losses | (79,776) | (3) | (112,246) | (4) | (201,475) | (5) | |||
Investment loss | $(67,988) | $(53,122) | $(195,397) | ||||||
December 31, 2024 | December 31, 2023 | |||||||||
Investments | Cost | Unrealized Gains | Unrealized Losses | Carrying Amount | Carrying Amount | |||||
Publicly traded companies | $188,653 | $24,262 | $(107,248) | $105,667 | $159,566 | |||||
Entities that report NAV | 518,074 | 126,077 | (34,285) | 609,866 | 671,532 | |||||
Entities that do not report NAV: | ||||||||||
Entities with observable price changes | 99,932 | 77,761 | (2,956) | 174,737 | 174,268 | |||||
Entities without observable price changes | 400,487 | — | — | 400,487 | 368,654 | |||||
Investments accounted for under the equity method | N/A | N/A | N/A | 186,228 | 75,498 | |||||
December 31, 2024 | $1,207,146 | (6) | $228,100 | $(144,489) | $1,476,985 | $1,449,518 | ||||
December 31, 2023 | $1,177,072 | $320,445 | $(123,497) | $1,449,518 |
Public/Private Mix (Cost) | Tenant/Non-Tenant Mix (Cost) | |
Liquidity | Minimal Outstanding Borrowings and Significant Availability on Unsecured Senior Line of Credit | |||||
(in millions) | ||||||
$5.7B | ![]() | |||||
(In millions) | ||||||
Availability under our unsecured senior line of credit, net of amounts outstanding under our commercial paper program | $5,000 | |||||
Cash, cash equivalents, and restricted cash | 560 | |||||
Availability under our secured construction loan | 46 | |||||
Investments in publicly traded companies | 106 | |||||
Liquidity as of December 31, 2024 | $5,712 | |||||
Description | Stated Rate | Aggregate Commitments | Outstanding Balance(1) | Remaining Commitments/ Liquidity | ||||
Availability under our unsecured senior line of credit, net of amounts outstanding under our commercial paper program | SOFR+0.855% | $5,000,000 | $— | $5,000,000 | ||||
Cash, cash equivalents, and restricted cash | 559,847 | |||||||
Construction loan | SOFR+2.70% | $195,300 | $149,322 | 45,706 | ||||
Investments in publicly traded companies | 105,667 | |||||||
Liquidity as of December 31, 2024 | $5,711,220 |
Year Ended December 31, | |||||
2024 | 2023 | Change | |||
Net cash provided by operating activities | $1,504,524 | $1,630,550 | $(126,026) | ||
Net cash used in investing activities | $(1,510,695) | $(2,500,619) | $989,924 | ||
Net cash (used in) provided by financing activities | $(93,315) | $674,156 | $(767,471) |
Year Ended December 31, | |||||
2024 | 2023 | Increase (Decrease) | |||
Sources of cash from investing activities: | |||||
Proceeds from sales of real estate | $1,220,206 | $1,195,743 | $24,463 | ||
Sales of and distributions from non-real estate investments | 173,927 | 183,396 | (9,469) | ||
Change in escrow deposits | 3,864 | — | 3,864 | ||
Return of capital from unconsolidated real estate joint ventures | 2,916 | — | 2,916 | ||
1,400,913 | 1,379,139 | 21,774 | |||
Uses of cash for investing activities: | |||||
Purchases of real estate | 248,699 | 265,750 | (17,051) | ||
Additions to real estate | 2,422,625 | 3,418,296 | (995,671) | ||
Change in escrow deposits | — | 5,582 | (5,582) | ||
Investments in unconsolidated real estate joint ventures | 3,927 | 658 | 3,269 | ||
Additions to non-real estate investments | 236,357 | 189,472 | 46,885 | ||
2,911,608 | 3,879,758 | (968,150) | |||
Net cash used in investing activities | $1,510,695 | $2,500,619 | $(989,924) |
Year Ended December 31, | |||||
2024 | 2023 | Change | |||
Borrowings under secured notes payable | $29,919 | $59,957 | $(30,038) | ||
Repayments of borrowings under secured notes payable | (32) | (30) | (2) | ||
Proceeds from issuance of unsecured senior notes payable | 998,806 | 996,205 | 2,601 | ||
Borrowings under unsecured senior line of credit | — | 1,245,000 | (1,245,000) | ||
Repayments of borrowings under unsecured senior line of credit | — | (1,245,000) | 1,245,000 | ||
Proceeds from issuances under commercial paper program | 13,010,600 | 9,234,000 | 3,776,600 | ||
Repayments of borrowings under commercial paper program | (13,110,600) | (9,134,000) | (3,976,600) | ||
Payments of loan fees | (35,871) | (16,047) | (19,824) | ||
Changes related to debt | 892,822 | 1,140,085 | (247,263) | ||
Contributions from and sales of noncontrolling interests | 306,473 | 547,391 | (240,918) | ||
Distributions to and purchases of noncontrolling interests | (308,636) | (245,091) | (63,545) | ||
Proceeds from issuance of common stock | 27,103 | 103,846 | (76,743) | ||
Repurchase of common stock | (50,107) | — | (50,107) | ||
Dividends on common stock | (898,557) | (847,483) | (51,074) | ||
Taxes paid related to net settlement of equity awards | (62,413) | (24,592) | (37,821) | ||
Net cash (used in) provided by financing activities | $(93,315) | $674,156 | $(767,471) |
Key Sources and Uses of Capital (In millions) | 2025 Guidance | |||||
Range | Midpoint | |||||
Sources of capital: | ||||||
Reduction in debt | $(40) | $(340) | $(190) | |||
Net cash provided by operating activities after dividends | 425 | 525 | 475 | |||
Dispositions and sales of partial interests(1) | 1,200 | 2,200 | 1,700 | |||
Total sources of capital | $1,585 | $2,385 | $1,985 | |||
Uses of capital: | ||||||
Construction | $1,450 | $2,050 | $1,750 | |||
Acquisitions and other opportunistic uses of capital(2) | — | 200 | 100 | |||
Ground lease prepayment(3) | 135 | 135 | 135 | |||
Total uses of capital | $1,585 | $2,385 | $1,985 | |||
Reduction in debt (included above): | ||||||
Issuance of unsecured senior notes payable | $300 | $900 | $600 | |||
Repayment of secured notes payable | (600) | (600) | (600) | |||
Unsecured senior line of credit, commercial paper program, and other | 260 | (640) | (190) | |||
Net reduction in debt | $(40) | $(340) | $(190) | |||
Year Ended December 31, 2024 | |||||
Average Debt Outstanding | Weighted-Average Interest Rate | ||||
Long-term fixed-rate debt | $12,049,708 | 3.77% | |||
Short-term variable-rate unsecured senior line of credit and commercial paper program debt | 643,545 | 5.40 | |||
Blended-average interest rate | 12,693,253 | 3.85 | |||
Loan fee amortization and annual facility fee related to unsecured senior line of credit | N/A | 0.12 | |||
Total/weighted average | $12,693,253 | 3.97% | |||
Covenant Ratios(1) | Requirement | December 31, 2024 | ||
Total Debt to Total Assets | Less than or equal to 60% | 29% | ||
Secured Debt to Total Assets | Less than or equal to 40% | 0.4% | ||
Consolidated EBITDA(2) to Interest Expense | Greater than or equal to 1.5x | 11.0x | ||
Unencumbered Total Asset Value to Unsecured Debt | Greater than or equal to 150% | 330% |
Covenant Ratios(1) | Requirement | December 31, 2024 | |||
Leverage Ratio | Less than or equal to 60.0% | 29.5% | |||
Secured Debt Ratio | Less than or equal to 45.0% | 0.3% | |||
Fixed-Charge Coverage Ratio | Greater than or equal to 1.50x | 3.91x | |||
Unsecured Interest Coverage Ratio | Greater than or equal to 1.75x | 10.38x |
Total | |||
Balance as of December 31, 2023 | $(15,896) | ||
Other comprehensive loss before reclassifications | (29,719) | ||
Reclassification adjustment for loss included in net income | (637) | (1) | |
Net other comprehensive loss | (30,356) | ||
Balance as of December 31, 2024 | $(46,252) |
December 31, | ||||
2024 | 2023 | |||
Assets: | ||||
Cash, cash equivalents, and restricted cash | $103,993 | $210,755 | ||
Other assets | 153,913 | 115,373 | ||
Total assets | $257,906 | $326,128 | ||
Liabilities: | ||||
Unsecured senior notes payable | $12,094,465 | $11,096,028 | ||
Unsecured senior line of credit and commercial paper | — | 99,952 | ||
Other liabilities | 542,322 | 504,659 | ||
Total liabilities | $12,636,787 | $11,700,639 | ||
Year Ended December 31, | ||||
2024 | 2023 | |||
Total revenues | $59,023 | $54,230 | ||
Total expenses | (349,437) | (273,990) | ||
Net loss | (290,414) | (219,760) | ||
Net income attributable to unvested restricted stock awards | (13,394) | (11,195) | ||
Net loss attributable to Alexandria Real Estate Equities, Inc.’s common stockholders | $(303,808) | $(230,955) | ||
Noncontrolling Interest Share of Consolidated Real Estate Joint Ventures | Our Share of Unconsolidated Real Estate Joint Ventures | ||||||
December 31, 2024 | December 31, 2024 | ||||||
Three Months Ended | Year Ended | Three Months Ended | Year Ended | ||||
Net income | $46,150 | $187,784 | $6,635 | $7,059 | |||
Depreciation and amortization of real estate assets | 34,986 | 129,711 | 1,061 | 4,238 | |||
Gain on sales of real estate | (5,025) | (5,025) | (3,328) | (3,328) | |||
Funds from operations | $76,111 | $312,470 | $4,368 | $7,969 | |||
Year Ended December 31, | |||||
2024 | 2023 | 2022 | |||
Net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic and diluted | $309,555 | $92,444 | $513,268 | ||
Depreciation and amortization of real estate assets | 1,191,524 | 1,080,529 | 988,363 | ||
Noncontrolling share of depreciation and amortization from consolidated real estate JVs | (129,711) | (115,349) | (107,591) | ||
Our share of depreciation and amortization from unconsolidated real estate JVs | 4,238 | 3,589 | 3,666 | ||
Gain on sales of real estate | (127,615) | (1) | (277,037) | (537,918) | |
Impairment of real estate – rental properties and land | 192,455 | (2) | 450,428 | 20,899 | |
Allocation to unvested restricted stock awards | (8,696) | (5,175) | (1,118) | ||
Funds from operations attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted(3) | 1,431,750 | 1,229,429 | 879,569 | ||
Unrealized losses on non-real estate investments | 112,246 | 201,475 | 412,193 | ||
Impairment of non-real estate investments | 58,090 | (4) | 74,550 | 20,512 | |
Impairment of real estate | 30,613 | (2) | 10,686 | 44,070 | |
Loss on early extinguishment of debt | — | — | 3,317 | ||
Acceleration of stock compensation expense due to executive officer resignations | — | 20,295 | 7,185 | ||
Provision for expected credit losses on financial instruments | (434) | (5) | — | — | |
Allocation to unvested restricted stock awards | (3,188) | (4,121) | (5,137) | ||
Funds from operations attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, as adjusted | $1,629,077 | $1,532,314 | $1,361,709 |
Year Ended December 31, | ||||||
(Per share) | 2024 | 2023 | 2022 | |||
Net income per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted | $1.80 | $0.54 | $3.18 | |||
Depreciation and amortization of real estate assets | 6.20 | 5.67 | 5.47 | |||
Gain on sales of real estate | (0.74) | (1.62) | (3.33) | |||
Impairment of real estate – rental properties and land | 1.12 | 2.64 | 0.13 | |||
Allocation to unvested restricted stock awards | (0.06) | (0.04) | (0.01) | |||
Funds from operations per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted | 8.32 | 7.19 | 5.44 | |||
Unrealized losses on non-real estate investments | 0.65 | 1.18 | 2.55 | |||
Impairment of non-real estate investments | 0.34 | 0.44 | 0.13 | |||
Impairment of real estate | 0.18 | 0.06 | 0.27 | |||
Loss on early extinguishment of debt | — | — | 0.02 | |||
Acceleration of stock compensation expense due to executive officer resignations | — | 0.12 | 0.04 | |||
Allocation to unvested restricted stock awards | (0.02) | (0.02) | (0.03) | |||
Funds from operations per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, as adjusted | $9.47 | $8.97 | $8.42 | |||
Weighted-average shares of common stock outstanding – diluted(1) | 172,071 | 170,909 | 161,659 |
Three Months Ended December 31, | Year Ended December 31, | |||||||
2024 | 2023 | 2024 | 2023 | |||||
Net (loss) income | $(16,095) | $(42,658) | $510,733 | $280,994 | ||||
Interest expense | 55,659 | 31,967 | 185,838 | 74,204 | ||||
Income taxes | 1,855 | 1,322 | 6,678 | 5,887 | ||||
Depreciation and amortization | 330,108 | 285,246 | 1,202,380 | 1,093,473 | ||||
Stock compensation expense | 12,477 | 34,592 | 59,634 | 82,858 | ||||
Gain on sales of real estate | (101,806) | (62,227) | (129,312) | (277,037) | ||||
Unrealized losses (gains) on non-real estate investments | 79,776 | (19,479) | 112,246 | 201,475 | ||||
Impairment of real estate | 186,564 | 271,890 | 223,068 | 461,114 | ||||
Impairment of non-real estate investments | 20,266 | 23,094 | 58,090 | 74,550 | ||||
Provision for expected credit losses on financial instruments | (434) | — | (434) | — | ||||
Adjusted EBITDA | $568,370 | $523,747 | $2,228,921 | $1,997,518 | ||||
Total revenues | $788,945 | $757,216 | $3,116,394 | $2,885,699 | ||||
Adjusted EBITDA margin | 72% | 69% | 72% | 69% |
Three Months Ended December 31, | Year Ended December 31, | |||||||
2024 | 2023 | 2024 | 2023 | |||||
Adjusted EBITDA | $568,370 | $523,747 | $2,228,921 | $1,997,518 | ||||
Interest expense | $55,659 | $31,967 | $185,838 | $74,204 | ||||
Capitalized interest | 81,586 | 89,115 | 330,961 | 363,978 | ||||
Amortization of loan fees | (4,620) | (4,059) | (17,130) | (15,486) | ||||
Amortization of debt discounts | (333) | (309) | (1,309) | (1,207) | ||||
Cash interest and fixed charges | $132,292 | $116,714 | $498,360 | $421,489 | ||||
Fixed-charge coverage ratio: | ||||||||
– quarter annualized | 4.3x | 4.5x | N/A | N/A | ||||
– trailing 12 months | N/A | N/A | 4.5x | 4.7x |
December 31, | |||
2024 | 2023 | ||
Total assets | $37,527,449 | $36,771,402 | |
Accumulated depreciation | 5,625,179 | 4,985,019 | |
Gross assets | $43,152,628 | $41,756,421 | |
Percentage of | ||||||
Book Value | Gross Assets | Annual Rental Revenue | ||||
Under construction projects | $3,893,557 | 9% | —% | |||
Income-producing/potential cash flows/covered land play(1) | 2,965,853 | 7 | 1 | |||
Land | 1,759,317 | 4 | — | |||
$8,618,727 | 20% | 1% | ||||
Dev/Redev | RSF of Lease Expirations Targeted for Development and Redevelopment | |||||||||
Property/Submarket | 2025 | 2026 | Thereafter(1) | Total | ||||||
Priority anticipated projects: | ||||||||||
311 Arsenal Street/Cambridge/Inner Suburbs | Redev | 25,312 | — | — | 25,312 | |||||
10210 Campus Point Drive/University Town Center | Dev | 9,558 | — | 52,620 | 62,178 | |||||
1020 Red River Street/Austin | Redev | 126,034 | — | — | 126,034 | |||||
160,904 | — | 52,620 | 213,524 | |||||||
Future projects: | ||||||||||
446, 458, 500, and 550 Arsenal Street/Cambridge/Inner Suburbs | Dev | — | — | 375,898 | 375,898 | |||||
Other/Greater Boston | Redev | — | — | 167,549 | 167,549 | |||||
1122 and 1150 El Camino Real/South San Francisco | Dev | — | — | 375,232 | 375,232 | |||||
3875 Fabian Way/Greater Stanford | Dev | — | — | 228,000 | 228,000 | |||||
2100, 2200, and 2400 Geng Road/Greater Stanford | Dev | — | — | 78,501 | 78,501 | |||||
960 Industrial Road/Greater Stanford | Dev | — | — | 112,590 | 112,590 | |||||
Campus Point by Alexandria/University Town Center | Dev | 269,048 | — | 101,966 | 371,014 | |||||
Sequence District by Alexandria/Sorrento Mesa | Dev/Redev | — | — | 686,290 | 686,290 | |||||
410 West Harrison Street/Elliott Bay | Dev | — | — | 17,205 | 17,205 | |||||
Other/Seattle | Dev | — | — | 75,663 | 75,663 | |||||
100 Capitola Drive/Research Triangle | Dev | — | — | 34,527 | 34,527 | |||||
1001 Trinity Street/Austin | Dev | 72,938 | — | — | 72,938 | |||||
Canada | Redev | — | — | 247,743 | 247,743 | |||||
341,986 | — | 2,501,164 | 2,843,150 | |||||||
502,890 | — | 2,553,784 | 3,056,674 | |||||||
Annual Rental Revenue | Development and Redevelopment Pipeline RSF | ||
Megacampus | $1,605,730 | 20,130,433 | |
Core and non-core | 487,258 | 9,392,253 | |
Total | $2,092,988 | 29,522,686 | |
Megacampus as a percentage of annual rental revenue and of total development and redevelopment pipeline RSF | 77% | 68% |
December 31, | |||
2024 | 2023 | ||
Secured notes payable | $149,909 | $119,662 | |
Unsecured senior notes payable | 12,094,465 | 11,096,028 | |
Unsecured senior line of credit and commercial paper | — | 99,952 | |
Unamortized deferred financing costs | 77,649 | 76,329 | |
Cash and cash equivalents | (552,146) | (618,190) | |
Restricted cash | (7,701) | (42,581) | |
Preferred stock | — | — | |
Net debt and preferred stock | $11,762,176 | $10,731,200 | |
Adjusted EBITDA: | |||
– quarter annualized | $2,273,480 | $2,094,988 | |
– trailing 12 months | $2,228,921 | $1,997,518 | |
Net debt and preferred stock to Adjusted EBITDA: | |||
– quarter annualized | 5.2x | 5.1x | |
– trailing 12 months | 5.3x | 5.4x |
Year Ended December 31, | ||||||
2024 | 2023 | 2022 | ||||
Net income | $510,733 | $280,994 | $670,701 | |||
Equity in earnings of unconsolidated real estate joint ventures | (7,059) | (980) | (645) | |||
General and administrative expenses | 168,359 | 199,354 | 177,278 | |||
Interest expense | 185,838 | 74,204 | 94,203 | |||
Depreciation and amortization | 1,202,380 | 1,093,473 | 1,002,146 | |||
Impairment of real estate | 223,068 | 461,114 | 64,969 | |||
Loss on early extinguishment of debt | — | — | 3,317 | |||
Gain on sales of real estate | (129,312) | (277,037) | (537,918) | |||
Investment loss | 53,122 | 195,397 | 331,758 | |||
Net operating income | 2,207,129 | 2,026,519 | 1,805,809 | |||
Straight-line rent revenue | (143,329) | (133,917) | (118,003) | |||
Amortization of deferred revenue related to tenant-funded and -built landlord improvements | (1,543) | — | — | |||
Amortization of acquired below-market leases | (85,679) | (93,331) | (74,346) | |||
Provision for expected credit losses on financial instruments | (434) | — | — | |||
Net operating income (cash basis) | $1,976,144 | $1,799,271 | $1,613,460 | |||
Net operating income (from above) | $2,207,129 | $2,026,519 | $1,805,809 | |||
Total revenues | $3,116,394 | $2,885,699 | $2,588,962 | |||
Operating margin | 71% | 70% | 70% |
Year Ended December 31, | ||||||
2024 | 2023 | 2022 | ||||
Income from rentals | $3,049,706 | $2,842,456 | $2,576,040 | |||
Rental revenues | (2,304,339) | (2,143,971) | (1,950,098) | |||
Tenant recoveries | $745,367 | $698,485 | $625,942 | |||
Year Ended December 31, | |||||
2024 | 2023 | 2022 | |||
Unencumbered net operating income | $2,192,608 | $2,022,177 | $1,790,033 | ||
Encumbered net operating income | 14,521 | 4,342 | 15,776 | ||
Total net operating income | $2,207,129 | $2,026,519 | $1,805,809 | ||
Unencumbered net operating income as a percentage of total net operating income | 99.3% | 99.8% | 99.1% |
Year Ended December 31, | |||||
2024 | 2023 | 2022 | |||
Basic shares for earnings per share | 172,071 | 170,909 | 161,659 | ||
Unvested RSAs with forfeitable rights to dividends | — | — | — | ||
Forward Agreements | — | — | — | ||
Diluted shares for earnings per share | 172,071 | 170,909 | 161,659 | ||
Basic shares for funds from operations per share and funds from operations per share, as adjusted | 172,071 | 170,909 | 161,659 | ||
Unvested RSAs with forfeitable rights to dividends | — | — | — | ||
Forward Agreements | — | — | — | ||
Diluted shares for funds from operations per share, and funds from operations per share, as adjusted | 172,071 | 170,909 | 161,659 | ||
Weighted-average unvested RSAs with nonforfeitable rights to dividends used in the allocations of net income, funds from operations, and funds from operations, as adjusted | 2,779 | 2,325 | 1,723 |
December 31, | |||
2024 | 2023 | ||
Annualized effect on future earnings due to variable-rate debt: | |||
Rate increase of 1% | $(350) | $(339) | |
Rate decrease of 1% | $350 | $339 | |
Effect on fair value of total consolidated debt: | |||
Rate increase of 1% | $(753,483) | $(742,460) | |
Rate decrease of 1% | $860,921 | $847,335 |
December 31, | |||
2024 | 2023 | ||
Equity price risk: | |||
Fair value increase of 10% | $147,699 | $144,952 | |
Fair value decrease of 10% | $(147,699) | $(144,952) |
December 31, | |||
2024 | 2023 | ||
Effect on potential future earnings due to foreign currency exchange rate: | |||
Rate increase of 10% | $17 | $311 | |
Rate decrease of 10% | $(17) | $(311) | |
Effect on the fair value of net investment in foreign subsidiaries due to foreign currency exchange rate: | |||
Rate increase of 10% | $36,644 | $37,346 | |
Rate decrease of 10% | $(36,644) | $(37,346) |
Number of securities to be issued upon exercise of outstanding options, warrants, and rights (a) | Weighted-average exercise price of outstanding options, warrants, and rights (b) | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c) | ||||
Equity Compensation Plan Approved by Stockholders — Amended and Restated 1997 Stock Award and Incentive Plan | — | — | 4,665,494 |
Page | |
Report of Independent Registered Public Accounting Firm (PCAOB ID: 000 | F-1 |
Audited Consolidated Financial Statements of Alexandria Real Estate Equities, Inc.: | |
Consolidated Balance Sheets as of December 31, 2024 and 2023 ................................................................................................ | F-3 |
Consolidated Financial Statements for the Years Ended December 31, 2024, 2023, and 2022: ............................................... | |
Consolidated Statements of Operations ........................................................................................................................................ | F-4 |
Consolidated Statements of Comprehensive Income ................................................................................................................. | F-5 |
Consolidated Statements of Changes in Stockholders’ Equity and Noncontrolling Interests ............................................... | F-6 |
Consolidated Statements of Cash Flows ...................................................................................................................................... | F-8 |
Notes to Consolidated Financial Statements ....................................................................................................................................... | F-10 |
Schedule III – Consolidated Financial Statement Schedule of Real Estate and Accumulated Depreciation ............................ | F-55 |
Exhibit Number | Exhibit Title | Incorporated by Reference to: | Date Filed | |||
3.1* | Form 10-Q | August 14, 1997 | ||||
3.2* | Form 10-Q | August 14, 1997 | ||||
3.3* | Form 8-K | May 12, 2017 | ||||
3.4* | Form 8-K | May 19, 2022 | ||||
3.5* | Form 10-Q | August 13, 1999 | ||||
3.6* | Form 8-K | February 10, 2000 | ||||
3.7* | Form 8-K | February 10, 2000 | ||||
3.8* | Form 8-A | January 18, 2002 | ||||
3.9* | Form 8-A | June 28, 2004 | ||||
3.10* | Form 8-K | March 25, 2008 | ||||
3.11* | Form 8-K | March 14, 2012 | ||||
3.12* | Form 8-K | May 12, 2017 | ||||
3.13* | Form 8-K | December 9, 2024 | ||||
4.1* | Form 10-Q | May 5, 2011 | ||||
4.2* | Form 8-K | February 29, 2012 |
Exhibit Number | Exhibit Title | Incorporated by Reference to: | Date Filed | |||
4.3* | Form 8-K | July 18, 2014 | ||||
4.4* | Form 8-K | July 18, 2014 | ||||
4.5* | Form 8-K | November 17, 2015 | ||||
4.6* | Form 8-K | November 17, 2015 | ||||
4.7* | Form 8-K | November 17, 2015 | ||||
4.8* | Form 8-K | June 10, 2016 | ||||
4.9* | Form 8-K | June 10, 2016 | ||||
4.10* | Form 8-K | March 3, 2017 | ||||
4.11* | Form 8-K | March 3, 2017 | ||||
4.12* | Form 8-K | March 3, 2017 | ||||
4.13* | Form 8-K | November 20, 2017 | ||||
4.14* | Form 8-K | November 20, 2017 | ||||
4.15* | Form 8-K | June 21, 2018 | ||||
4.16* | Form 8-K | June 21, 2018 | ||||
4.17* | Form 8-K | June 21, 2018 | ||||
4.18* | Form 8-K | March 21, 2019 | ||||
4.19* | Form 8-K | March 21, 2019 | ||||
4.20* | Form 8-K | March 21, 2019 | ||||
4.21* | Form 8-K | March 21, 2019 | ||||
4.22* | Form 8-K | July 15, 2019 | ||||
4.23* | Form 8-K | July 15, 2019 | ||||
4.24* | Form 8-K | July 15, 2019 | ||||
4.25* | Form 8-K | September 12, 2019 | ||||
4.26* | Form 8-K | July 15, 2019 |
Exhibit Number | Exhibit Title | Incorporated by Reference to: | Date Filed | |||
4.27* | Form 8-K | September 12, 2019 | ||||
4.28* | Form 8-K | September 12, 2019 | ||||
4.29* | Form 8-K | March 26, 2020 | ||||
4.30* | Form 8-K | March 26, 2020 | ||||
4.31* | Form 8-K | August 5, 2020 | ||||
4.32* | Form 8-K | August 5, 2020 | ||||
4.33* | Form 8-K | February 18, 2021 | ||||
4.34* | Form 8-K | February 18, 2021 | ||||
4.35* | Form 8-K | February 18, 2021 | ||||
4.36* | Form 8-K | February 18, 2021 | ||||
4.37* | Form 8-K | February 16, 2022 | ||||
4.38* | Form 8-K | February 16, 2022 | ||||
4.39* | Form 8-K | February 16, 2022 | ||||
4.40* | Form 8-K | February 16, 2022 | ||||
4.41* | Form 8-K | February 16, 2023 | ||||
4.42* | Form 8-K | February 16, 2023 | ||||
4.43* | Form 8-K | February 16, 2023 | ||||
4.44* | Form 8-K | February 16, 2023 | ||||
4.45* | Form 8-K | February 15, 2024 | ||||
4.46* | Form 8-K | February 15, 2024 | ||||
4.47* | Form 8-K | February 15, 2024 | ||||
4.48* | Form of 5.625% Senior Notes due 2054 (included in Exhibit 4.47 above) | Form 8-K | February 15, 2024 | |||
4.49 | N/A | Filed herewith | ||||
10.1* | Form 10-Q | October 21, 2024 | ||||
10.2*(1) | Form 8-K | May 16, 2024 | ||||
10.3(1) | N/A | Filed herewith |
Exhibit Number | Exhibit Title | Incorporated by Reference to: | Date Filed | |||
10.4(1) | N/A | Filed herewith | ||||
10.5(1) | N/A | Filed herewith | ||||
10.6(1) | N/A | Filed herewith | ||||
10.7(1) | N/A | Filed herewith | ||||
10.8(1) | N/A | Filed herewith | ||||
10.9*(1) | Form 8-K | April 7, 2015 | ||||
10.10*(1) | Form 8-K | July 3, 2017 | ||||
10.11*(1) | Form 10-Q | May 1, 2018 | ||||
10.12*(1) | Form 8-K | January 18, 2019 | ||||
10.13*(1) | Form 10-Q | July 27, 2020 | ||||
10.14*(1) | Form 10-Q | October 23, 2023 | ||||
10.15*(1) | Form 10-K | January 29, 2024 | ||||
10.16*(1) | Form 8-K | December 9, 2024 | ||||
10.17*(1) | Form 10-Q | July 31, 2018 | ||||
10.18*(1) | Form 10-K | January 29, 2024 | ||||
10.19*(1) | Form 10-Q | October 23, 2023 | ||||
10.20*(1) | Form 10-Q | July 31, 2018 | ||||
10.21*(1) | Form 10-K | January 31, 2022 | ||||
10.22(1) | N/A | Filed herewith | ||||
10.23(1) | N/A | Filed herewith | ||||
10.24*(1) | Form 10-K | March 1, 2011 |
Exhibit Number | Exhibit Title | Incorporated by Reference to: | Date Filed | |||
14.1 | N/A | Filed herewith | ||||
19.1 | N/A | Filed herewith | ||||
21.1 | N/A | Filed herewith | ||||
22.1 | N/A | Filed herewith | ||||
23.1 | N/A | Filed herewith | ||||
31.1 | N/A | Filed herewith | ||||
31.2 | N/A | Filed herewith | ||||
31.3 | N/A | Filed herewith | ||||
32.0 | N/A | Filed herewith | ||||
97.1(1) | N/A | Filed herewith | ||||
101.1 | The following materials from the Company’s annual report on Form 10-K for the three months and year ended December 31, 2024, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Consolidated Balance Sheets as of December 31, 2024 and 2023, (ii) Consolidated Statements of Operations for the years ended December 31, 2024, 2023, and 2022, (iii) Consolidated Statements of Comprehensive Income for the years ended December 31, 2024, 2023, and 2022, (iv) Consolidated Statements of Changes in Stockholders’ Equity and Noncontrolling Interests for the years ended December 31, 2024, 2023, and 2022, (v) Consolidated Statements of Cash Flows for the years ended December 31, 2024, 2023, and 2022, (vi) Notes to Consolidated Financial Statements, and (vii) Schedule III — Consolidated Financial Statement Schedule of Real Estate and Accumulated Depreciation of the Company. | N/A | Filed herewith | |||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | N/A | Filed herewith |
ALEXANDRIA REAL ESTATE EQUITIES, INC. | |||
Dated: | January 27, 2025 | By: | /s/ Joel S. Marcus |
Joel S. Marcus Executive Chairman (Principal Executive Officer) | |||
/s/ Peter M. Moglia | |||
Peter M. Moglia Chief Executive Officer and Chief Investment Officer (Principal Executive Officer) |
Signature | Title | Date | ||
/s/ Joel S. Marcus | Executive Chairman (Principal Executive Officer) | January 27, 2025 | ||
Joel S. Marcus | ||||
/s/ Peter M. Moglia | Chief Executive Officer and Chief Investment Officer (Principal Executive Officer) | January 27, 2025 | ||
Peter M. Moglia | ||||
/s/ Marc E. Binda | Chief Financial Officer and Treasurer (Principal Financial Officer) | January 27, 2025 | ||
Marc E. Binda | ||||
/s/ Andres R. Gavinet | Chief Accounting Officer (Principal Accounting Officer) | January 27, 2025 | ||
Andres R. Gavinet | ||||
/s/ Steven R. Hash | Lead Director | January 27, 2025 | ||
Steven R. Hash | ||||
/s/ James P. Cain | Director | January 27, 2025 | ||
James P. Cain | ||||
/s/ Cynthia L. Feldmann | Director | January 27, 2025 | ||
Cynthia L. Feldmann | ||||
/s/ Maria C. Freire | Director | January 27, 2025 | ||
Maria C. Freire | ||||
/s/ Richard H. Klein | Director | January 27, 2025 | ||
Richard H. Klein | ||||
/s/ Sheila K. McGrath | Director | January 27, 2025 | ||
Sheila K. McGrath | ||||
/s/ Michael A. Woronoff | Director | January 27, 2025 | ||
Michael A. Woronoff |
Description of the Matter | At December 31, 2024, the carrying value of the Company’s investments in real estate was $32.1 billion. As discussed in Note 2 to the consolidated financial statements, the Company reviews current activities and changes in the business conditions of its investment in real estate to determine the existence of any triggering events or impairment indicators requiring an impairment analysis. If triggering events or impairment indicators are identified, the Company will review an estimate of the future undiscounted cash flows of the particular investment in real estate which will include a probability-weighted approach if multiple outcomes are under consideration. Auditing the Company’s evaluation of whether its investments in real estate are recoverable was complex and involved a high degree of subjectivity in evaluating management’s key assumptions in estimating the undiscounted future cash flows, including projected rental rates, exit capitalization rates, construction costs for projects under development, and probability-weighting multiple scenarios under consideration, as they are based on assumptions about construction costs, available market information, current and historical operating results, known trends and current market/ economic conditions that may affect the asset, and management’s assumptions about the use of the asset, including a probability-weighted approach if multiple outcomes are under consideration. | |
How we Addressed the Matter in Our Audit | We obtained an understanding, evaluated the design, and tested the operating effectiveness of the Company’s controls over the Company’s investments in real estate impairment assessment process. For example, we tested controls over management’s process for estimating and evaluating the assumptions used in the calculations of the future undiscounted cash flows for investments in real estate where impairment indicators existed. For real estate investments with identified indicators of impairment, we performed audit procedures over the Company’s estimation of the assets’ undiscounted future cash flows. For example, we compared significant assumptions used to estimate future cash flows to the Company’s historical accounting records or to available market data. We also tested the mathematical accuracy of management’s forecasted cash flows. Additionally, for certain assumptions, we assessed management’s sensitivity analyses in addition to performing our own sensitivity analyses to evaluate the changes in the undiscounted cash flows of the investments in real estate that would result from changes in the assumptions. |
December 31, | |||
2024 | 2023 | ||
Assets | |||
Investments in real estate | $ | $ | |
Investments in unconsolidated real estate joint ventures | |||
Cash and cash equivalents | |||
Restricted cash | |||
Tenant receivables | |||
Deferred rent | |||
Deferred leasing costs | |||
Investments | |||
Other assets | |||
Total assets | $ | $ | |
Liabilities, Noncontrolling Interests, and Equity | |||
Secured notes payable | $ | $ | |
Unsecured senior notes payable | |||
Unsecured senior line of credit and commercial paper | |||
Accounts payable, accrued expenses, and other liabilities | |||
Dividends payable | |||
Total liabilities | |||
Commitments and contingencies | |||
Redeemable noncontrolling interests | |||
Alexandria Real Estate Equities, Inc.’s stockholders’ equity: | |||
Common stock, $ December 31, 2024 and 2023; outstanding as of December 31, 2024 and 2023, respectively | |||
Additional paid-in capital | |||
Accumulated other comprehensive loss | ( | ( | |
Alexandria Real Estate Equities, Inc.’s stockholders’ equity | |||
Noncontrolling interests | |||
Total equity | |||
Total liabilities, noncontrolling interests, and equity | $ | $ |
Year Ended December 31, | |||||
2024 | 2023 | 2022 | |||
Revenues: | |||||
Income from rentals | $ | $ | $ | ||
Other income | |||||
Total revenues | |||||
Expenses: | |||||
Rental operations | |||||
General and administrative | |||||
Interest | |||||
Depreciation and amortization | |||||
Impairment of real estate | |||||
Loss on early extinguishment of debt | |||||
Total expenses | |||||
Equity in earnings of unconsolidated real estate joint ventures | |||||
Investment loss | ( | ( | ( | ||
Gain on sales of real estate | |||||
Net income | |||||
Net income attributable to noncontrolling interests | ( | ( | ( | ||
Net income attributable to Alexandria Real Estate Equities, Inc.’s stockholders | |||||
Net income attributable to unvested restricted stock awards | ( | ( | ( | ||
Net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders | $ | $ | $ | ||
Net income per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders: | |||||
Basic | $ | $ | $ | ||
Diluted | $ | $ | $ |
Year Ended December 31, | |||||
2024 | 2023 | 2022 | |||
Net income | $ | $ | $ | ||
Other comprehensive (loss) income | |||||
Unrealized (losses) gains on foreign currency translation: | |||||
Unrealized foreign currency translation (losses) gains arising during the period | ( | ( | |||
Reclassification adjustment for gains included in net income | ( | ||||
Unrealized (losses) gains on foreign currency translation, net | ( | ( | |||
Total other comprehensive (loss) income | ( | ( | |||
Comprehensive income | |||||
Less: comprehensive income attributable to noncontrolling interests | ( | ( | ( | ||
Comprehensive income attributable to Alexandria Real Estate Equities, Inc.’s stockholders | $ | $ | $ |
Alexandria Real Estate Equities, Inc.’s Stockholders’ Equity | ||||||||||||||||
Number of Common Shares | Common Stock | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Loss | Noncontrolling Interests | Total Equity | Redeemable Noncontrolling Interests | |||||||||
Balance as of December 31, 2021 | $ | $ | $ | $( | $ | $ | $ | |||||||||
Net income | — | — | — | — | ||||||||||||
Total other comprehensive loss | — | — | — | — | ( | — | ( | — | ||||||||
Contributions from and sales of noncontrolling interests | — | — | — | — | ||||||||||||
Distributions to and redemption of noncontrolling interests | — | — | ( | — | — | ( | ( | ( | ||||||||
Issuance of common stock | — | — | — | — | ||||||||||||
Issuance pursuant to stock plan | — | — | — | — | ||||||||||||
Taxes related to net settlement of equity awards | ( | ( | ( | — | — | — | ( | — | ||||||||
Dividends declared on common stock ($ | — | — | — | ( | — | — | ( | — | ||||||||
Reclassification of distributions in excess of earnings | — | — | ( | — | — | — | ||||||||||
Balance as of December 31, 2022 | ( | |||||||||||||||
Net income | — | — | — | — | ||||||||||||
Total other comprehensive income | — | — | — | — | — | — | ||||||||||
Contributions from and sales of noncontrolling interests | — | — | — | — | ||||||||||||
Distributions to and redemption of noncontrolling interests | — | — | — | — | ( | ( | ( | |||||||||
Transfer of noncontrolling interest | — | — | — | — | — | ( | ( | |||||||||
Issuance of common stock | — | — | — | — | ||||||||||||
Issuance pursuant to stock plan | — | — | — | — | ||||||||||||
Taxes related to net settlement of equity awards | ( | ( | ( | — | — | — | ( | — | ||||||||
Dividends declared on common stock ($ | — | — | — | ( | — | — | ( | — | ||||||||
Reclassification of distributions in excess of earnings | — | — | ( | — | — | — | ||||||||||
Balance as of December 31, 2023 | $ | $ | $ | $( | $ | $ | $ |
Alexandria Real Estate Equities, Inc.’s Stockholders’ Equity | ||||||||||||||||
Number of Common Shares | Common Stock | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Loss | Noncontrolling Interests | Total Equity | Redeemable Noncontrolling Interests | |||||||||
Balance as of December 31, 2023 | $ | $ | $ | $( | $ | $ | $ | |||||||||
Net income | — | — | — | — | ||||||||||||
Total other comprehensive loss | — | — | — | — | ( | — | ( | — | ||||||||
Contributions from and sales of noncontrolling interests | — | — | — | — | ||||||||||||
Distributions to and redemption of noncontrolling interests | — | — | ( | — | — | ( | ( | ( | ||||||||
Transfer of noncontrolling interests | — | — | — | — | — | ( | ( | |||||||||
Reallocation of capital to joint venture partner | — | — | ( | — | — | — | ||||||||||
Issuance of common stock | — | — | — | — | ||||||||||||
Issuance pursuant to stock plan | — | — | — | — | ||||||||||||
Taxes related to net settlement of equity awards | ( | ( | ( | — | — | — | ( | — | ||||||||
Repurchase of common stock | ( | ( | ( | — | — | — | ( | — | ||||||||
Dividends declared on common stock ($ | — | — | — | ( | — | — | ( | — | ||||||||
Reclassification of distributions in excess of earnings | — | — | ( | — | — | — | ||||||||||
Balance as of December 31, 2024 | $ | $ | $ | $( | $ | $ | $ |
Alexandria Real Estate Equities, Inc. Consolidated Statements of Cash Flows (In thousands) | |||||
Year Ended December 31, | |||||
2024 | 2023 | 2022 | |||
Operating Activities | |||||
Net income | $ | $ | $ | ||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||
Depreciation and amortization | |||||
Impairment of real estate | |||||
Gain on sales of real estate | ( | ( | ( | ||
Loss on early extinguishment of debt | |||||
Equity in earnings of unconsolidated real estate joint ventures | ( | ( | ( | ||
Distributions of earnings from unconsolidated real estate joint ventures | |||||
Amortization of loan fees | |||||
Amortization of debt discounts | |||||
Amortization of acquired above- and below-market leases | ( | ( | ( | ||
Deferred rent | ( | ( | ( | ||
Stock compensation expense | |||||
Investment loss | |||||
Changes in operating assets and liabilities: | |||||
Tenant receivables | ( | ( | |||
Deferred leasing costs | ( | ( | ( | ||
Other assets | ( | ( | |||
Accounts payable, accrued expenses, and other liabilities | ( | ||||
Net cash provided by operating activities | |||||
Investing Activities | |||||
Proceeds from sales of real estate | |||||
Additions to real estate | ( | ( | ( | ||
Purchases of real estate | ( | ( | ( | ||
Change in escrow deposits | ( | ||||
Investments in unconsolidated real estate joint ventures | ( | ( | ( | ||
Return of capital from unconsolidated real estate joint ventures | |||||
Additions to non-real estate investments | ( | ( | ( | ||
Sales of and distributions from non-real estate investments | |||||
Net cash used in investing activities | $( | $( | $( | ||
The accompanying notes are an integral part of these consolidated financial statements. |
Alexandria Real Estate Equities, Inc. Consolidated Statements of Cash Flows (In thousands) | |||||
Year Ended December 31, | |||||
2024 | 2023 | 2022 | |||
Financing Activities | |||||
Borrowings under secured notes payable | $ | $ | $ | ||
Repayments of borrowings under secured notes payable | ( | ( | ( | ||
Payment for the defeasance of secured note payable | ( | ||||
Proceeds from issuances of unsecured senior notes payable | |||||
Borrowings under unsecured senior line of credit | |||||
Repayments of borrowings under unsecured senior line of credit | ( | ( | |||
Proceeds from issuances under commercial paper program | |||||
Repayments of borrowings under commercial paper program | ( | ( | ( | ||
Payments of loan fees | ( | ( | ( | ||
Taxes paid related to net settlement of equity awards | ( | ( | ( | ||
Proceeds from issuance of common stock | |||||
Repurchase of common stock | ( | ||||
Dividends on common stock | ( | ( | ( | ||
Contributions from and sales of noncontrolling interests | |||||
Distributions to and purchases of noncontrolling interests | ( | ( | ( | ||
Net cash (used in) provided by financing activities | ( | ||||
Effect of foreign exchange rate changes on cash and cash equivalents | ( | ( | ( | ||
Net (decrease) increase in cash, cash equivalents, and restricted cash | ( | ( | |||
Cash, cash equivalents, and restricted cash as of the beginning of period | |||||
Cash, cash equivalents, and restricted cash as of the end of period | $ | $ | $ | ||
Supplemental Disclosure and Non-Cash Investing and Financing Activities: | |||||
Cash paid during the period for interest, net of interest capitalized | $ | $ | $ | ||
Accrued construction for current-period additions to real estate | $ | $ | $ | ||
Contribution of assets from and issuance of noncontrolling interest to real estate joint venture partner | $ | $ | $ | ||
Transfer of real estate assets and/or equipment from tenants | $ | $ | $ | ||
Reallocation of additional paid-in-capital to consolidated joint venture partner’s non-controlling interest | $ | $ | $ | ||
Notes receivable issued in connection with sales of real estate | $ | $ | $ | ||
Initial recognition of right-of-use asset and lease liability | $ | $ | $ | ||
Payable for purchase of noncontrolling interest | $ | $( | $ |
Year Ended December 31, | ||||||
2024 | 2023 | 2022 | ||||
Income from rentals: | ||||||
Revenues subject to the lease accounting standard: | ||||||
Operating leases | $ | $ | $ | |||
Direct financing leases | ||||||
Revenues subject to the lease accounting standard | ||||||
Revenues subject to the revenue recognition accounting standard | ||||||
Income from rentals | ||||||
Other income | ||||||
Total revenues | $ | $ | $ |
December 31, | ||||
2024 | 2023 | |||
Rental properties: | ||||
Land (related to rental properties) | $ | $ | ||
Buildings and building improvements | ||||
Other improvements | ||||
Rental properties | ||||
Development and redevelopment projects | ||||
Gross investments in real estate | ||||
Less: accumulated depreciation | ( | ( | ||
Investments in real estate assets held for sale(1) | ||||
Investments in real estate | $ | $ |
December 31, | |||
2024 | 2023 | ||
Investments in real estate | $ | $ | |
Other assets | |||
Total assets | |||
Total liabilities | ( | ( | |
Total accumulated other comprehensive income | |||
Net assets classified as held for sale | $ | $ |
Square Footage | ||||||||||||
Property | Submarket/Market | Date of Purchase | Number of Properties | Future Development | Operating With Future Development/ Redevelopment | Purchase Price(1) | ||||||
285, 299, 307, and 345 Dorchester Avenue(2) | Seaport Innovation District/Greater Boston | 1/30/24 | — | $ | ||||||||
428 Westlake Avenue North | Lake Union/Seattle | 10/1/24 | — | |||||||||
Other | ||||||||||||
Total | $ |
December 31, | ||||
2024 | 2023 | |||
Acquired below-market leases | $ | $ | ||
Accumulated amortization | ( | ( | ||
$ | $ |
Year | Amount | |
2025 | $ | |
2026 | ||
2027 | ||
2028 | ||
2029 | ||
Thereafter | ||
Total | $ |
December 31, | ||||
2024 | 2023 | |||
Acquired in-place leases | $ | $ | ||
Accumulated amortization | ( | ( | ||
$ | $ |
Year | Amount | |
2025 | $ | |
2026 | ||
2027 | ||
2028 | ||
2029 | ||
Thereafter | ||
Total | $ |
Property | Submarket/Market | Date of Sale | Interest Sold | RSF | Land and Future SF | Sales Price | Gain on Sales of Real Estate | ||||||||
4755 and 4757 Nexus Center Drive and 4796 Executive Drive | University Town Center/San Diego | 12/30/24 | — | $ | (1) | $ | |||||||||
14225 Newbrook Drive | Northern Virginia/Maryland | 10/15/24 | — | ||||||||||||
1165 Eastlake Avenue East | Lake Union/Seattle | 9/12/24 | — | ||||||||||||
9444 Waples Street (50% consolidated JV) | Sorrento Mesa/San Diego | 12/23/24 | — | (2) | (2) | ||||||||||
6040 George Watts Hill Drive | Research Triangle/Research Triangle | 12/10/24 | — | ||||||||||||
100 Minuteman Road | Other/Greater Boston | 11/15/24 | — | ||||||||||||
849 and 863 Mitten Road and 866 Malcolm Road | South San Francisco/San Francisco Bay Area | 11/20/24 | — | — | |||||||||||
99 A Street | Seaport Innovation District/ Greater Boston | 3/8/24 | — | — | |||||||||||
219 East 42nd Street | New York City/New York City | 7/9/24 | — | — | |||||||||||
6101 Quadrangle Drive | Research Triangle/Research Triangle | 12/16/24 | — | — | |||||||||||
Other | |||||||||||||||
$ | |||||||||||||||
One Moderna Way | Route 128/Greater Boston | 12/17/24 | — | (3) | |||||||||||
215 First Street, 150 Second Street, and 11 Hurley Street | Cambridge/Greater Boston | 12/20/24 | — | ||||||||||||
10048 and 10219 Meanley Drive and 10277 Scripps Ranch Boulevard | Sorrento Mesa/San Diego | 12/20/24 | — | (1) | |||||||||||
$ | (4) | ||||||||||||||
1401/1413 Research Boulevard ( | Rockville/Maryland | 10/31/24 | (5) | — | $ | (5) | $ | (5) | |||||||
Property | Market | Submarket | Our Ownership Interest(1) | ||||||
Consolidated real estate joint ventures(2): | |||||||||
50 and 60 Binney Street | Greater Boston | Cambridge/Inner Suburbs | |||||||
75/125 Binney Street | Greater Boston | Cambridge/Inner Suburbs | |||||||
100 and 225 Binney Street and 300 Third Street | Greater Boston | Cambridge/Inner Suburbs | |||||||
99 Coolidge Avenue | Greater Boston | Cambridge/Inner Suburbs | |||||||
15 Necco Street | Greater Boston | Seaport Innovation District | |||||||
285, 299, 307, and 345 Dorchester Avenue | Greater Boston | Seaport Innovation District | |||||||
Alexandria Center® for Science and Technology – Mission Bay(3) | San Francisco Bay Area | Mission Bay | |||||||
1450 Owens Street | San Francisco Bay Area | Mission Bay | (4) | ||||||
601, 611, 651, 681, 685, and 701 Gateway Boulevard | San Francisco Bay Area | South San Francisco | |||||||
751 Gateway Boulevard | San Francisco Bay Area | South San Francisco | |||||||
211 and 213 East Grand Avenue | San Francisco Bay Area | South San Francisco | |||||||
500 Forbes Boulevard | San Francisco Bay Area | South San Francisco | |||||||
Alexandria Center® for Life Science – Millbrae | San Francisco Bay Area | South San Francisco | |||||||
3215 Merryfield Row | San Diego | Torrey Pines | |||||||
Campus Point by Alexandria(5) | San Diego | University Town Center | |||||||
5200 Illumina Way | San Diego | University Town Center | |||||||
9625 Towne Centre Drive | San Diego | University Town Center | |||||||
SD Tech by Alexandria(6) | San Diego | Sorrento Mesa | |||||||
Pacific Technology Park | San Diego | Sorrento Mesa | |||||||
Summers Ridge Science Park(7) | San Diego | Sorrento Mesa | |||||||
1201 and 1208 Eastlake Avenue East | Seattle | Lake Union | |||||||
199 East Blaine Street | Seattle | Lake Union | |||||||
400 Dexter Avenue North | Seattle | Lake Union | |||||||
800 Mercer Street | Seattle | Lake Union | |||||||
Unconsolidated real estate joint ventures(2): | |||||||||
1655 and 1725 Third Street | San Francisco Bay Area | Mission Bay | |||||||
1450 Research Boulevard | Maryland | Rockville | (8) | ||||||
101 West Dickman Street | Maryland | Beltsville | (8) |
Property(1) | Consolidation Model | Voting Interest | Consolidation Analysis | Conclusion | |||||
50 and 60 Binney Street | VIE model | Not applicable under VIE model | Consolidated | ||||||
75/125 Binney Street | We have: | ||||||||
100 and 225 Binney Street and 300 Third Street | |||||||||
99 Coolidge Avenue | (i) | The power to direct the activities of the joint venture that most significantly affect its economic performance; and | |||||||
15 Necco Street | |||||||||
285, 299, 307, and 345 Dorchester Avenue | |||||||||
Alexandria Center® for Science and Technology – Mission Bay | |||||||||
1450 Owens Street | |||||||||
601, 611, 651, 681, 685, and 701 Gateway Boulevard | |||||||||
751 Gateway Boulevard | |||||||||
211 and 213 East Grand Avenue | (ii) | Benefits that can be significant to the joint venture. | |||||||
500 Forbes Boulevard | |||||||||
Alexandria Center® for Life Science – Millbrae | |||||||||
3215 Merryfield Row | |||||||||
Campus Point by Alexandria | |||||||||
5200 Illumina Way | Therefore, we are the primary beneficiary of each VIE. | ||||||||
9625 Towne Centre Drive | |||||||||
SD Tech by Alexandria | |||||||||
Pacific Technology Park | |||||||||
Summers Ridge Science Park | |||||||||
1201 and 1208 Eastlake Avenue East | |||||||||
199 East Blaine Street | |||||||||
400 Dexter Avenue North | |||||||||
800 Mercer Street | |||||||||
1450 Research Boulevard | We do not control the joint venture and are therefore not the primary beneficiary. | Equity method of accounting | |||||||
101 West Dickman Street | |||||||||
1655 and 1725 Third Street | Voting model | Does not exceed 50% | Our voting interest is 50% or less. | ||||||
December 31, | ||||
2024 | 2023 | |||
Investments in real estate | $ | $ | ||
Cash and cash equivalents | ||||
Other assets | ||||
Total assets | $ | $ | ||
Secured notes payable | $ | $ | ||
Other liabilities | ||||
Mandatorily redeemable noncontrolling interest | ||||
Total liabilities | ||||
Redeemable noncontrolling interests | ||||
Alexandria Real Estate Equities, Inc.’s share of equity | ||||
Noncontrolling interests’ share of equity | ||||
Total liabilities and equity | $ | $ | ||
December 31, | ||||
Property | 2024 | 2023 | ||
1655 and 1725 Third Street | $ | $ | ||
1450 Research Boulevard | ||||
101 West Dickman Street | ||||
Other | ||||
$ | $ |
At 100% | Our Share | |||||||||||||||
Unconsolidated Joint Venture | Maturity Date | Stated Rate | Interest Rate(1) | Aggregate Commitment | Debt Balance(2) | |||||||||||
1655 and 1725 Third Street(3) | $ | $ | ||||||||||||||
101 West Dickman Street | SOFR + | (4) | ||||||||||||||
1450 Research Boulevard | SOFR + | (4) | ||||||||||||||
$ | $ |
Year | Amount | |
2025 | $ | |
2026 | ||
2027 | ||
2028 | ||
2029 | ||
Thereafter | ||
Total | $ |
December 31, | ||||
2024 | 2023 | |||
Gross investment in direct financing lease | $ | $ | ||
Less: unearned income on direct financing lease | ( | ( | ||
Less: provision for expected credit losses | ( | ( | ||
Net investment in direct financing lease | $ | $ |
Year | Total | |
2025 | $ | |
2026 | ||
2027 | ||
2028 | ||
2029 | ||
Thereafter | ||
Total | $ |
Year Ended December 31, | ||||||
2024 | 2023 | 2022 | ||||
Income from rentals: | ||||||
Revenues subject to the lease accounting standard: | ||||||
Operating leases | $ | $ | $ | |||
Direct financing leases | ||||||
Revenues subject to the lease accounting standard | ||||||
Revenues subject to the revenue recognition accounting standard | ||||||
Income from rentals | $ | $ | $ |
December 31, | ||||
2024 | 2023 | |||
Deferred leasing costs | $ | $ | ||
Accumulated amortization | ( | ( | ||
Deferred leasing costs, net | $ | $ |
Year | Total | |
2025 | $ | |
2026 | ||
2027 | ||
2028 | ||
2029 | ||
Thereafter | ||
Total future payments under our operating leases in which we are the lessee | ||
Effect of discounting | ( | |
Operating lease liability | $ |
Year Ended December 31, | ||||||
2024 | 2023 | 2022 | ||||
Gross operating lease costs | $ | $ | $ | |||
Capitalized lease costs | ( | ( | ( | |||
Expenses for operating leases in which we are the lessee | $ | $ | $ | |||
December 31, | |||
2024 | 2023 | ||
Cash and cash equivalents | $ | $ | |
Restricted cash: | |||
Funds held in escrow for real estate acquisitions | |||
Other | |||
Total | $ | $ |
December 31, 2024 | |||||||
Cost | Unrealized Gains | Unrealized Losses | Carrying Amount | ||||
Publicly traded companies | $ | $ | $( | $ | |||
Entities that report NAV | ( | ||||||
Entities that do not report NAV: | |||||||
Entities with observable price changes | ( | ||||||
Entities without observable price changes | |||||||
Investments accounted for under the equity method | N/A | N/A | N/A | ||||
Total investments | $ | $ | $( | $ |
December 31, 2023 | |||||||
Cost | Unrealized Gains | Unrealized Losses | Carrying Amount | ||||
Publicly traded companies | $ | $ | $( | $ | |||
Entities that report NAV | ( | ||||||
Entities that do not report NAV: | |||||||
Entities with observable price changes | ( | ||||||
Entities without observable price changes | |||||||
Investments accounted for under the equity method | N/A | N/A | N/A | ||||
Total investments | $ | $ | $( | $ | |||
Year Ended December 31, | ||||||
2024 | 2023 | 2022 | ||||
Realized gains | $ | (1) | $ | $ | ||
Unrealized losses | ( | ( | ( | |||
Investment loss | $( | $( | $( | |||
December 31, | |||
2024 | 2023 | ||
Acquired in-place leases | $ | $ | |
Deferred compensation plan | |||
Deferred financing costs – unsecured senior line of credit | (1) | ||
Deposits | |||
Furniture, fixtures, equipment, and software | |||
Net investment in direct financing lease | |||
Notes receivable | (2) | ||
Operating lease right-of-use assets | (3) | ||
Other assets | |||
Prepaid expenses | |||
Property, plant, and equipment | |||
Total | $ | $ |
Notes Receivable | Effective Interest Rate | Maturity Date | Balance | |||
Secured by real estate assets in San Diego | $ | |||||
Other | ||||||
Less: provision for expected credit losses | ( | |||||
Notes receivable | $ |
Fair Value Measurement Using | ||||||||
Description | Total | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | ||||
Investments in publicly traded companies: | ||||||||
As of December 31, 2024 | $ | $ | $ | $ | ||||
As of December 31, 2023 | $ | $ | $ | $ |
Fair Value Measurement Using | |||||||||||
Description | Carrying Amount | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||
Real estate assets held for sale with carrying values adjusted to fair value less costs to sell: | |||||||||||
As of December 31, 2024 | $ | (1) | $ | $ | $ | (2) | |||||
As of December 31, 2023 | $ | (1) | $ | $ | $ | (2) | |||||
Investments in privately held entities that do not report NAV: | |||||||||||
As of December 31, 2024 | $ | $ | $ | (3) | $ | (4) | |||||
As of December 31, 2023 | $ | $ | $ | (3) | $ | (4) |
December 31, 2024 | |||||||||
Book Value | Fair Value Hierarchy | Estimated Fair Value | |||||||
Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||
Liabilities: | |||||||||
Secured notes payable | $ | $ | $ | $ | $ | ||||
Unsecured senior notes payable | $ | $ | $ | $ | $ | ||||
Unsecured senior line of credit | $ | $ | $ | $ | $ | ||||
Commercial paper program | $ | $ | $ | $ | $ |
December 31, 2023 | |||||||||
Book Value | Fair Value Hierarchy | Estimated Fair Value | |||||||
Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||
Liabilities: | |||||||||
Secured notes payable | $ | $ | $ | $ | $ | ||||
Unsecured senior notes payable | $ | $ | $ | $ | $ | ||||
Unsecured senior line of credit | $ | $ | $ | $ | $ | ||||
Commercial paper program | $ | $ | $ | $ | $ |
Stated Rate | Interest Rate(1) | Maturity Date(2) | Principal Payments Remaining for the Periods Ending December 31, | Unamortized (Deferred Financing Cost), (Discount) Premium | ||||||||||||||||||||
Debt | 2025 | 2026 | 2027 | 2028 | 2029 | Thereafter | Principal | Total | ||||||||||||||||
Secured notes payable | ||||||||||||||||||||||||
Greater Boston(3) | SOFR+ | $ | $ | $ | $ | $ | $ | $ | $( | $ | ||||||||||||||
San Francisco Bay Area | ||||||||||||||||||||||||
Secured debt weighted-average interest rate/subtotal | ( | |||||||||||||||||||||||
Unsecured senior line of credit and commercial paper program(4) | (4) | N/A | (4) | (4) | ||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ||||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured senior notes payable | ( | |||||||||||||||||||||||
Unsecured debt weighted-average interest rate/subtotal | ( | |||||||||||||||||||||||
Weighted-average interest rate/total | $ | $ | $ | $ | $ | $ | $ | $( | $ |
Fixed-Rate Debt | Variable-Rate Debt | Weighted-Average | ||||||||||
Interest | Remaining Term (in years) | |||||||||||
Total | Percentage | Rate(1) | ||||||||||
Secured notes payable | $ | $ | $ | |||||||||
Unsecured senior notes payable | ||||||||||||
Unsecured senior line of credit and commercial paper program | (2) | N/A | (2) | (3) | ||||||||
Total/weighted average | $ | $ | $ | (3) | ||||||||
Percentage of total debt |
Year Ended December 31, | ||||||
2024 | 2023 | 2022 | ||||
Interest incurred | $ | $ | $ | |||
Capitalized interest | ( | ( | ( | |||
Interest expense | $ | $ | $ |
December 31, | |||
2024 | 2023 | ||
Accounts payable and accrued expenses | $ | $ | |
Accrued construction | |||
Acquired below-market leases | |||
Conditional asset retirement obligations | |||
Deferred rent liabilities | |||
Operating lease liability | (1) | ||
Unearned rent and tenant security deposits | |||
Other liabilities | |||
Total | $ | $ |
Year Ended December 31, | |||||
2024 | 2023 | 2022 | |||
Net income | $510,733 | $280,994 | $670,701 | ||
Net income attributable to noncontrolling interests | ( | ( | ( | ||
Net income attributable to unvested RSAs with nonforfeitable rights to dividends | ( | ( | ( | ||
Numerator for basic and diluted EPS – net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders | $ | $ | $ | ||
Denominator for basic EPS – weighted-average shares of common stock outstanding | |||||
Dilutive effect of unvested RSAs with forfeitable rights to dividends | |||||
Dilutive effect of forward equity sales agreements | |||||
Denominator for diluted EPS – weighted-average shares of common stock outstanding | |||||
Net income per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders: | |||||
Basic | $ | $ | $ | ||
Diluted | $ | $ | $ |
Year Ended December 31, | |||||
2024 | 2023 | 2022 | |||
Ordinary income | |||||
Return of capital | |||||
Capital gains at 25% | |||||
Capital gains at 20% | |||||
Total | |||||
Dividends declared | $ | $ | $ |
Year Ended December 31, | ||||
2023 | 2022 | |||
Net income | $ | $670,701 | ||
Net income attributable to noncontrolling interests | ( | ( | ||
Book/tax differences: | ||||
Rental revenue recognition | ( | |||
Depreciation and amortization | ||||
Share-based compensation | ||||
Interest expense | ( | ( | ||
Sales of property | ( | |||
Impairments | ||||
Non-real estate investments loss | ||||
Other | ||||
Taxable income before dividend deduction | ||||
Dividend deduction necessary to eliminate taxable income(1) | ( | ( | ||
Estimated income subject to federal income tax | $ | $ |
Number of Share Awards | Weighted-Average Grant Date Fair Value per Share | |||||||
Outstanding at December 31, 2021 | $ | |||||||
Granted | $ | |||||||
Vested | ( | $ | ||||||
Forfeited | ( | $ | ||||||
Outstanding at December 31, 2022 | $ | |||||||
Granted | $ | |||||||
Vested | ( | $ | ||||||
Forfeited | ( | $ | ||||||
Outstanding at December 31, 2023 | $ | |||||||
Granted | $ | |||||||
Vested | ( | $ | ||||||
Forfeited | ( | $ | ||||||
Outstanding at December 31, 2024 | $ | |||||||
Year Ended December 31, | ||||||||
2024 | 2023 | 2022 | ||||||
Total grant date fair value of stock awards vested | $ | $ | $ | |||||
Total gross compensation recognized for stock awards | $ | $ | $ | |||||
Capitalized stock compensation | $ | $ | $ |
Year Ended December 31, | |||||
(in thousands) | 2024 | 2023 | 2022 | ||
Reportable segment revenues: | |||||
Revenues from external customers | $ | $ | $ | ||
Other income | |||||
Reportable segment total revenues | |||||
Reportable segment total rental operating expenses | ( | ( | ( | ||
Reportable segment net operating income (reportable segment profit or loss) | $ | $ | $ |
Year Ended December 31, | |||||
(in thousands) | 2024 | 2023 | 2022 | ||
Reconciliation of reportable segment revenues to consolidated total revenues: | |||||
Reportable segment total revenues | $ | $ | $ | ||
All other revenues | |||||
Consolidated revenues | $ | $ | $ | ||
Reconciliation of reportable segment total rental operating expenses to consolidated rental operations: | |||||
Reportable segment total rental operating expenses | $( | $( | $( | ||
All other rental operating expenses | ( | ( | ( | ||
Consolidated rental operations | $( | $( | $( | ||
Reconciliation of reportable segment net operating income to consolidated net income: | |||||
Reportable segment net operating income (reportable segment profit or loss) | $ | $ | $ | ||
All other revenues | |||||
All other rental operating expenses | ( | ( | ( | ||
Other items not allocated to segments: | |||||
General and administrative | ( | ( | ( | ||
Interest expense | ( | ( | ( | ||
Depreciation and amortization | ( | ( | ( | ||
Impairment of real estate | ( | ( | ( | ||
Loss on early extinguishment of debt | ( | ||||
Equity in earnings of unconsolidated real estate joint ventures | |||||
Investment loss | ( | ( | ( | ||
Gain on sale of real estate | |||||
Consolidated net income | $ | $ | $ |
As of December 31, | |||
(in thousands) | 2024 | 2023 | |
Reconciliation of reportable segment assets to consolidated investments in real estate assets | |||
Reportable segment investments in real estate | $ | $ | |
All other investments in real estate | |||
Consolidated investments in real estate | $ | $ |
Initial Costs | Costs Capitalized Subsequent to Acquisitions | Total Costs | ||||||||||||||||||||||
Property | Market | Encumbrances | Land | Buildings & Improvements | Buildings & Improvements | Land | Buildings & Improvements | Total(1) | Accumulated Depreciation(2) | Net Cost Basis | Date of Construction(3) | Date Acquired | ||||||||||||
Alexandria Center® at Kendall Square | Greater Boston | $ | $ | $ | $ | $ | $ | $ | $( | $ | 1981 - 2023 | 2005 - 2022 | ||||||||||||
Alexandria Center® at One Kendall Square | Greater Boston | ( | 1985 - 2023 | 2016 - 2022 | ||||||||||||||||||||
Alexandria Technology Square® | Greater Boston | ( | 2001 - 2012 | 2006 | ||||||||||||||||||||
The Arsenal on the Charles | Greater Boston | ( | 2000 - 2024 | 2019 - 2021 | ||||||||||||||||||||
480 Arsenal Way 446, 458, 500, and 550 Arsenal Street, and 99 Coolidge Avenue | Greater Boston | ( | 1962 - 2023 | 2000 - 2022 | ||||||||||||||||||||
Alexandria Center® for Life Science – Fenway | Greater Boston | ( | 2019 - 2024 | 2021 | ||||||||||||||||||||
285, 299, 307, and 345 Dorchester Avenue | Greater Boston | N/A | 2024 | |||||||||||||||||||||
5, 10, and 15 Necco Street | Greater Boston | ( | 2019 - 2023 | 2019 | ||||||||||||||||||||
Alexandria Center® for Life Science – Waltham | Greater Boston | ( | 1999 - 2024 | 2020 - 2022 | ||||||||||||||||||||
19, 215, 225, and 235 Presidential Way | Greater Boston | ( | 1999 - 2001 | 2005 - 2022 | ||||||||||||||||||||
Other | Greater Boston | ( | Various | Various | ||||||||||||||||||||
Alexandria Center® for Science and Technology – Mission Bay | San Francisco | ( | 2007 - 2014 | 2004 - 2017 | ||||||||||||||||||||
Alexandria Technology Center® – Gateway | San Francisco | ( | 1984 - 2024 | 2002 - 2020 | ||||||||||||||||||||
Alexandria Center® for Life Science – Millbrae | San Francisco | N/A | 2021 - 2022 | |||||||||||||||||||||
Alexandria Center® for Advanced Technologies – South San Francisco | San Francisco | ( | 2008 - 2019 | 2004 - 2005 | ||||||||||||||||||||
Alexandria Center® for Advanced Technologies – Tanforan | San Francisco | ( | 1971 - 2007 | 2021 - 2022 | ||||||||||||||||||||
Alexandria Center® for Life Science – South San Francisco | San Francisco | ( | 2012 - 2022 | 2002 - 2017 | ||||||||||||||||||||
500 Forbes Boulevard | San Francisco | ( | 2001 | 2007 | ||||||||||||||||||||
Alexandria Center® for Life Science – San Carlos | San Francisco | ( | 1970 - 2022 | 2017 - 2021 | ||||||||||||||||||||
Alexandria Stanford Life Science District | San Francisco | ( | 2002 - 2022 | 2003 - 2022 | ||||||||||||||||||||
3412, 3420, 3440, 3450, and 3460 Hillview Avenue | San Francisco | ( | 1978 - 2018 | 2020 - 2021 |
Initial Costs | Costs Capitalized Subsequent to Acquisitions | Total Costs | ||||||||||||||||||||||
Property | Market | Encumbrances | Land | Buildings & Improvements | Buildings & Improvements | Land | Buildings & Improvements | Total(1) | Accumulated Depreciation(2) | Net Cost Basis | Date of Construction(3) | Date Acquired | ||||||||||||
3825 and 3875 Fabian Way | San Francisco | $ | $ | $ | $ | $ | $ | $ | $( | $ | 1969 - 2014 | 2019 | ||||||||||||
2475 and 2625/2627/2631 Hanover Street and 1450 Page Mill Road | San Francisco | ( | 2000 - 2017 | 1999 - 2021 | ||||||||||||||||||||
2100, 2200, 2300, and 2400 Geng Road | San Francisco | ( | 1984 - 2019 | 2018 | ||||||||||||||||||||
3350 West Bayshore Road | San Francisco | ( | 1982 | 2005 | ||||||||||||||||||||
88 Bluxome Street | San Francisco | ( | N/A | 2017 | ||||||||||||||||||||
One Alexandria Square | San Diego | ( | 1995 - 2024 | 1994 - 2021 | ||||||||||||||||||||
ARE Torrey Ridge | San Diego | ( | 2004 - 2021 | 2016 | ||||||||||||||||||||
ARE Nautilus | San Diego | ( | 2009 - 2012 | 1994 - 1997 | ||||||||||||||||||||
One Alexandria North | San Diego | ( | 1980 - 1990 | 2020 | ||||||||||||||||||||
Campus Point by Alexandria | San Diego | ( | 1989 - 2024 | 2010 - 2022 | ||||||||||||||||||||
5200 Illumina Way | San Diego | ( | 2004 - 2017 | 2010 | ||||||||||||||||||||
9625 Towne Centre Drive | San Diego | ( | 2018 | 2014 | ||||||||||||||||||||
SD Tech by Alexandria | San Diego | ( | 2014 - 2022 | 2019 - 2020 | ||||||||||||||||||||
Sequence District by Alexandria | San Diego | ( | 1997 - 2000 | 2020 - 2021 | ||||||||||||||||||||
Pacific Technology Park | San Diego | ( | 1989 - 1991 | 2021 | ||||||||||||||||||||
Summers Ridge Science Park | San Diego | ( | 2005 | 2018 | ||||||||||||||||||||
Scripps Science Park by Alexandria | San Diego | ( | 2001 - 2022 | 2021 - 2022 | ||||||||||||||||||||
ARE Portola | San Diego | ( | 2005 - 2012 | 2007 | ||||||||||||||||||||
5810/5820 Nancy Ridge Drive | San Diego | ( | 2021 | 2004 | ||||||||||||||||||||
9877 Waples Street | San Diego | ( | 2020 | 2020 | ||||||||||||||||||||
5871 Oberlin Drive | San Diego | ( | 2021 | 2010 | ||||||||||||||||||||
3911, 3931, 3985, 4025, 4031, 4045, and 4075 Sorrento Valley Boulevard | San Diego | ( | 2007 - 2015 | 2010 - 2019 | ||||||||||||||||||||
11045 and 11055 Roselle Street | San Diego | ( | 2008 - 2014 | 2000 - 2013 | ||||||||||||||||||||
Other | San Diego | ( | Various | Various | ||||||||||||||||||||
Alexandria Center® for Life Science – Eastlake | Seattle | ( | 1997 - 2024 | 2002 - 2024 | ||||||||||||||||||||
Alexandria Center® for Life Science – South Lake Union | Seattle | ( | 1984 - 2017 | 2007 - 2024 | ||||||||||||||||||||
219 Terry Avenue North | Seattle | ( | 2012 | 2007 | ||||||||||||||||||||
1010 4th Avenue South | Seattle | N/A | 2020 | |||||||||||||||||||||
410 West Harrison Street and 410 Elliott Avenue West | Seattle | ( | 2006 - 2008 | 2004 | ||||||||||||||||||||
Alexandria Center® for Advanced Technologies – Canyon Park | Seattle | ( | 1985 - 2007 | 2021 - 2022 | ||||||||||||||||||||
Alexandria Center® for Advanced Technologies – Monte Villa Parkway | Seattle | ( | 1994 - 2024 | 2020 |
Initial Costs | Costs Capitalized Subsequent to Acquisitions | Total Costs | ||||||||||||||||||||||
Property | Market | Encumbrances | Land | Buildings & Improvements | Buildings & Improvements | Land | Buildings & Improvements | Total(1) | Accumulated Depreciation(2) | Net Cost Basis | Date of Construction(3) | Date Acquired | ||||||||||||
Other | Seattle | $ | $ | $ | $ | $ | $ | $ | $( | $ | Various | Various | ||||||||||||
Alexandria Center® for Life Science – Shady Grove | Maryland | ( | 1998 - 2024 | 2004 - 2021 | ||||||||||||||||||||
1330 Piccard Drive | Maryland | ( | 2005 | 1997 | ||||||||||||||||||||
1405 Research Boulevard | Maryland | ( | 2006 | 1997 | ||||||||||||||||||||
1500 and 1550 East Gude Drive | Maryland | ( | 1995 - 2003 | 1997 | ||||||||||||||||||||
5 Research Place | Maryland | ( | 2010 | 2001 | ||||||||||||||||||||
5 Research Court | Maryland | ( | 2007 | 2004 | ||||||||||||||||||||
12301 Parklawn Drive | Maryland | ( | 2007 | 2004 | ||||||||||||||||||||
Alexandria Technology Center® – Gaithersburg I | Maryland | ( | 1992 - 2019 | 1997 - 2019 | ||||||||||||||||||||
Alexandria Technology Center® – Gaithersburg II | Maryland | ( | 2000 - 2021 | 1997 - 2020 | ||||||||||||||||||||
20400 Century Boulevard | Maryland | ( | 2023 | 2021 | ||||||||||||||||||||
401 Professional Drive | Maryland | ( | 2007 | 1996 | ||||||||||||||||||||
950 Wind River Lane | Maryland | ( | 2009 | 2010 | ||||||||||||||||||||
620 Professional Drive | Maryland | ( | 2012 | 2005 | ||||||||||||||||||||
8000/9000/10000 Virginia Manor Road | Maryland | ( | 2003 | 1998 | ||||||||||||||||||||
Alexandria Center® for Life Science – Durham | Research Triangle | ( | 1985 - 2023 | 2020 - 2022 | ||||||||||||||||||||
Alexandria Center® for Advanced Technologies and AgTech– Research Triangle | Research Triangle | ( | 2007 - 2022 | 2012 - 2021 | ||||||||||||||||||||
Alexandria Center® for Sustainable Technologies | Research Triangle | ( | 1966 - 2022 | 1998 - 2022 | ||||||||||||||||||||
Alexandria Technology Center® – Alston | Research Triangle | ( | 1985 - 2009 | 1998 | ||||||||||||||||||||
Alexandria Innovation Center® – Research Triangle | Research Triangle | ( | 2005 - 2008 | 2000 | ||||||||||||||||||||
2525 East NC Highway 54 | Research Triangle | ( | 1995 | 2004 | ||||||||||||||||||||
407 Davis Drive | Research Triangle | ( | 1998 | 2013 | ||||||||||||||||||||
601 Keystone Park Drive | Research Triangle | ( | 2009 | 2006 | ||||||||||||||||||||
Alexandria Center® for NextGen Medicines | Research Triangle | N/A | 2021 | |||||||||||||||||||||
Alexandria Center® for Life Science – New York City | New York City | ( | 2010 - 2016 | 2006 | ||||||||||||||||||||
Alexandria Center® for Life Science – Long Island City | New York City | ( | 2022 | 2018 | ||||||||||||||||||||
Intersection Campus | Texas | ( | 2000 - 2019 | 2021 - 2022 | ||||||||||||||||||||
1001 Trinity Street and 1020 Red River Street | Texas | ( | 1987 - 1990 | 2022 |
Initial Costs | Costs Capitalized Subsequent to Acquisitions | Total Costs | ||||||||||||||||||||||
Property | Market | Encumbrances | Land | Buildings & Improvements | Buildings & Improvements | Land | Buildings & Improvements | Total(1) | Accumulated Depreciation(2) | Net Cost Basis | Date of Construction(3) | Date Acquired | ||||||||||||
Alexandria Center® for Advanced Technologies at The Woodlands | Texas | $ | $ | $ | $ | $ | $ | $ | $( | $ | 2002 - 2023 | 2020 | ||||||||||||
Other | Texas | Various | Various | |||||||||||||||||||||
Canada | Canada | ( | 1989 - 2023 | 2005 - 2023 | ||||||||||||||||||||
Various | Various | ( | Various | Various | ||||||||||||||||||||
North America | ( | |||||||||||||||||||||||
Asia | ( | 2015 | 2008 | |||||||||||||||||||||
$ | $ | $ | $ | $ | $ | $ | $( | $ |
December 31, | ||||||
Real Estate | 2024 | 2023 | 2022 | |||
Balance at beginning of period | $ | $ | $ | |||
Acquisitions (including real estate, land, and joint venture consolidation) | ||||||
Additions to real estate | ||||||
Deductions (including dispositions and direct financing leases) | ( | ( | ( | |||
Balance at end of period | $ | $ | $ | |||
December 31, | ||||||
Accumulated Depreciation | 2024 | 2023 | 2022 | |||
Balance at beginning of period | $ | $ | $ | |||
Depreciation expense on properties | ||||||
Sale of properties | ( | ( | ( | |||
Balance at end of period | $ | $ | $ |